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ABSTRACT 
EVALUATING DIFFERENTIAL GENE EXPRESSION USING RNA-SEQUENCING: A 
CASE STUDY IN DIET-INDUCED MOUSE MODEL ASSOCIATED WITH NON-
ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CXCL12-vs-TGFβ INDUCED 
FIBROBLAST TO MYOFIBROBLAST PHENOCONVERSION  
 
May 2019 
Arpa Samadder, B.S, M.S., University of Massachusetts Boston 
 
Directed by Professor Todd Riley 
 
Unlike the genome, cell transcriptome is dynamic and specific for a given cell developmental 
stage. Transcriptomics study is crucial to understand the functional elements of the genome to 
divulge molecular constituents of cells. The recent development of high-throughput sequencing 
technologies has provided an unprecedented method to sequence RNA and it has been 
emerging as the preferred technology for both characterization and quantification of the cell 
transcripts. Using “Tailor_Pipeline” we have analyzed diet-induced mouse and stromal 
fibroblast RNA-Seq samples and deciphers the differentially expressed genes that were 
significantly up- and downregulated and associated with several metabolic immune responses 
that presumably associated with liver disease. Analyzing the diet-induced mice model allowed 
us to encapsulate the transcriptional differences between diet-induced mice that can aid in the 
understanding of NAFLD and consequent liver pathogenesis. Identification of genes 
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downregulated in metabolic processes and upregulated in immune responses indicate that mice 
model exhibiting liver disease. Moreover, the finding of a premalignant signature suggests that 
NAFLD may begin to progress towards hepatocellular carcinoma much earlier than earlier 
consideration. 
Tissue fibrosis arises due to overgrowth, scarring of various tissues and is attributed to 
deposition of the extracellular matrix including collagen, influenced by the actions of several 
pro-fibrotic proteins that can induce myofibroblast phenoconversion. Though recent 
transcriptomics analysis reveals cellular identity, but its ability to provide biologically 
meaningful insights in fibrosis is largely unexplored. To unravel the mechanisms at the genetic 
level, we have considered TGFβ/TGFβR and CXCL12/CXCR4 transcriptomes in human 
stromal fibroblasts. Transcriptome profiling technology revealed CXCL12/CXCR4 axis is 
responsible for the activation of COPII vesicle formation, ubiquitination, and Golgi/ER 
localization/targeting. Especially, identification of CUL3 and KLHL12 are responsible for the 
transportation of procollagen from ER to the Golgi. Interestingly, over-expression of CUL3 
and KLHL12 are highly correlated with procollagen secretion by CXCL12-treated cells, but 
not in TGFβ-, treated cells. Moreover, this analysis showed how activation of the 
CXCL12/CXCR4 axis promotes procollagen I secretion that responsible for the deposition of 
ECM which is a characteristic of fibrosis. 
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CHAPTER 1 
               INTRODUCTION 
1.1 Context and motivation 
The chemistry Nobel Prize was awarded to Fred Sanger and Walter Gilbert, in 1980, for their 
crucial contribution towards the determination of base sequences in nucleic acids (Sanger et 
al., 1977 & Gilbert et al., 1973), since then many were involved in the developments of DNA 
sequencing technologies (Fiers et al., 1976). Development of these techniques conveyed a 
modernized approach to biological questions and, high throughput sequencing technologies 
such as RNA-Sequencing (RNA-Seq) has revolutionized the post genomic era, become an 
integral part of the biological research to access the cell transcriptome (Mardis, 2008).  
Bioinformatics is an interdisciplinary field that integrates computer science and 
biology to research, develop, and apply computational tools to manage and process large 
scale of biological data (Hogeweg and Hesper, 1978). Particularly, these computational tools 
are suitable to analyse data generated from high-throughput sequencing platforms. 
Consequently, the success of next-generation sequencing (NGS) technologies is strongly 
related with the creation of competent computational tools to deal with the dramatic increase 
of data (Shendure and Ji, 2008). 
Until the mid-1990s, gene expression studies were limited to measure transcription of 
few genes. But microarray technology changed this and allowed the study of hundreds or 
thousands of transcripts at a time. At that time, this technology revolutionized many areas of 
biology, from basic research to the understanding and treatment of human disease (Schena et 
al., 1995). In an analogous way, the recent availability of next-generation sequencing (NGS) 
analysis has opened new horizons to address the gene expression analysis, where initially 
NGS applications were mainly focusing on the sequencing of genomic DNA, this technology 
is now finding its way to be used in transcriptomics studies (Westermann et al., 2012). 
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An important biological aspect in recent year is to understand the complex and 
sophisticated mechanisms where deposition of the extracellular matrix (ECM) leads to 
develop progressive aging- and inflammation-associated fibrosis. Now tissue stiffness and 
urethral disfunction are due to the accumulation of ECM that leads to reduce tissue flexibility 
that lead to urinary flow block and development of lower urinary tract symptoms (LUTS). In 
this study, we have tried to encapsulate whether senescence-accelerated mouse prone 
(SAMP6) mice would also develop LUTS. Also, we have tried to see whether diet-induced 
obesity and type 2 Diabetes Mellitus (T2DM) have any influential role to propagate this 
disease. A global transcriptomics analysis can provide new insights into the disease process, 
leading to the identification of known and unknown transcripts, and overall gene expression 
regulation of different pathways and how they differ between the different samples under 
different diets (Gharaee-Kermani et al., 2013). 
 Dynamic remodeling of the extracellular matrix (ECM) deposition and gain an 
understanding of their role in fibrosis is a challenging factor recently. Fibrosis characterizes a 
contributing factor to the etiology of LUTS (Gharaee-Kermani et al., 2013). Several studies 
have shown that the aging prostate tissue is rich with inflammatory cells microenvironment 
and proteins. It is still unclear whether these inflammatory proteins, particularly CXC-type 
chemokines, can mediate fibroblast to myofibroblast phenoconversion and the ECM 
deposition which necessary for the development of prostatic tissue fibrosis (Rodríguez-
Nieves et al., 2016). In human stromal fibroblast, we are trying to determine the effect of 
TGFβ/TGFβR and CXCL12/CXCR4 transcriptomes and find out the difference between 
them. In addition to this we aimed to find out any significantly differentially expressed 
transcripts including coding and non-coding mRNAs that may promote myofibroblast 
phenoconversion. 
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1.2 Problem formulation 
This thesis has two underlying goals that are complementary to each other: the first is related 
to computational methodologies and the second to biologic knowledge. 
• Computational goal 
Firstly, I aim to integrate available bioinformatics tools in a congruent pipeline that can 
process RNA-Seq data and extract reliable biological conclusions from it. 
• Biological goal 
The second main goal is to use the developed tools to comprehend in which way NAFLD 
(Non-Alcoholic Fatty Liver Disease) is transcriptionally regulated. Furthermore, it has 
been well informed that tissue fibrosis is mediated by the actions of multiple pro-fibrotic 
proteins that can induce fibroblast to myofibroblast phenoconversion. This occurs through 
various signaling pathways such as Smads or MEK/Erk proteins. Apart from that the 
TGFβ/TGFβR and CXCL12/CXCR4 axes persuade myofibroblast phenoconversion 
independently through Smads and MEK/Erk proteins, respectively. To investigate these 
mechanisms at the genetic level, we aim is to elucidate the TGFβ/TGFβR and 
CXCL12/CXCR4 transcriptomes in human fibroblasts. 
1.3 Thesis Outline 
Apart from this introduction, this thesis is structured in six chapters.  
In chapter 2 I introduce the concept of gene expression, its main regulation points and 
the several used approaches to have insight into this information. Particularly, in section 2.4, I 
give special relevance to RNA-Seq data and the current methods that are used to access the 
gene expression profile and extract novel biological knowledge from this type of data. 
Chapter 3 presents a review on the diet-induce obesity mouse model to characterize 
the transcriptional landscape of NAFLD and compare it to the transcriptional signature of 
healthy control mice. More importantly, identification of the transcriptional signatures helps 
to detect of these diseases through the identification of novel markers. Moreover, in this 
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chapter, it is described the RNA-Seq mouse dataset that will be used in this thesis as a case 
study to test the developed ethodologies. 
Then, in chapter 4 I describe a pipeline developed to analyze an RNA-Seq dataset. As 
a case study, I used the implemented pipeline to process an RNA-Seq dataset extracted from 
SAMP6 strain mouse fed with high fat diet (HFD) and low-fat diet (LFD). From its output I 
conclude whether there are any significant transcript differences between the two phenotypes, 
up-regulating inflammation-related processes and down-regulating metabolism related 
processes in HFD-fed mice compared to LFD-fed mice. This analysis is described in section 
4.2. Then in section 4.3 I have discussed the detailed analysis of human fibroblast cell line 
where we have elucidated the TGFβ/TGFβR and CXCL12/CXCR4 transcriptomes in human 
fibroblasts. From the output I conclude the biological significance about the fibroblast to 
myofibroblast phenoconversion. 
Afterwards, in chapter 5, I have described the detail analysis of two case studies done 
by using our recently developed pipeline known as Tailor_Pipeline.  
Then, in chapter 6 I have discussed the overall journey of this analysis and how this 
pipeline helps to analyze the raw RNA-Seq data to extract the biological significance.  
Finally, in chapter 7 I have concluded the important aspects of the analysis. 
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CHAPTER 2 
GENE EXPRESSION 
2.1 Introductory note  
 Eukaryotic organisms have its genetic information encoded in molecules of 
deoxyribonucleic acid (DNA) which are packed and organized into the cell nucleus in 
structures called chromosomes. The monomers of DNA are called nucleotides and they are 
organized in a double-stranded helix. Nucleotides are comprised by a phosphate group, a 5-
carbon sugar, and a nitrogenous base. The genetic information in a DNA molecule is 
represented by the sequence of nucleotides containing one of four types of nucleobases: 
adenine (A), guanine (G), cytosine (C) and thymine (T).  
Following the Watson - Crick Model (Watson and Crick, 1953), the two strands that 
constitute the DNA molecule are held together by hydrogen bonds that can only be 
established between specific pairs of nucleobases: A with T and G with C. Because of this 
restriction, both strains are complementary to one another and, therefore, contain the same 
genetic information.  
2.2 The concept of gene expression 
    In 1958, the central dogma of molecular biology was firstly proposed by Francis Crick 
(Crick, 1958; Crick 1060). Particularly, central dogma states that information in nucleic acids 
can be transferred (Fig-1). Gene expression is the process by which a segment of DNA is 
copied into a ribonucleic acid (RNA) molecule which, in turn, will be used in the synthesis of 
functional gene products. Some RNA molecules can be the end product in themselves and 
some can be used as a template for the creation of other molecules such as proteins, in a 
process called translation. According to this distinction, RNAs can be classified as either 
messenger RNAs (mRNAs) or non-coding RNAs (ncRNAs). The genetic information is 
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transferred into an RNA molecule is designated by transcription and completed in the cell 
nucleus by an enzyme called RNA polymerase (RNA pol). 
The RNA polymerase catalyzes and forms the phosphodiester bonds that link the nucleotides 
together and form the sugar-phosphate backbone. In eukaryotes, there are multiple types of 
RNA polymerases (RNA pol) that synthesize various types of RNA. Firstly, RNA pol I 
transcribe ribosomal RNAs (rRNAs) which associated with ribosomal proteins, on which 
mRNA is translated into protein. Secondly, RNA pol II transcribes mainly protein-coding 
genes (mRNAs). Finally, RNA pol III catalyzes the transcription of transfer RNAs (tRNAs), 
which function as adaptors selecting amino acids and holding them in place on a ribosome for 
their incorporation into protein. As we have seen, DNA to protein synthesis occurs in a two-
step process. In the first step DNA to mRNA synthesis is called transcription. In the second 
step, called translation where the information in the mRNA is translated into protein. 
The transcription is a process of formation of the transcript (RNA). It takes place by the usual 
process of complementary base pairing, catalyzed and scrutinized by the enzyme RNA 
polymerase. It occurs unidirectionally in which RNA chain (transcript) is synthesized from 5′ 
to 3′ direction. Initiation, elongation, and termination are the three steps of the gene 
transcription process. Initiation process begins when the RNA pol molecule binds to the 
upstream region of the DNA at a specialized sequence called promoter. To occur this binding, 
RNA polymerase requires the involvement of many accessory proteins such as transcription 
factors (TFs). The transcription initiation complex can be formed by the combination of the 
transcription factors and RNA polymerase and this complex is responsible to initiate 
transcription. The RNA polymerase started to synthesize mRNA by corresponding 
complementary bases to the original DNA strand. These must assemble on promoter along 
with the polymerase before the polymerase can begin transcription. Once transcription is 
initiated, most of the TFs are released from the DNA. Elongation involves the movement of 
the transcription bubble by disruption of DNA structure. The enzyme moves along the DNA 
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and extends the growing RNA chain. As the enzyme moves, it unwinds the DNA helix to 
expose a new segment of the template in single-stranded condition and added nucleotides to 
the 3´ end of the growing RNA chain. Finally, transcription termination occurs after RNA pol 
reaches a termination site. At this point, RNA pol is released from the DNA and RNA is 
cleaved and released from the transcriptional complex. 
    Simultaneously to the transcription process, the translation takes place in the cytoplasm. 
The mRNA molecules undergo little or no modification after synthesis by RNA polymerase 
in prokaryotes. In contrast, processing of eukaryotic pre-mRNA involves 5’ capping, 3′ 
cleavage/Polyadenylation, splicing, and RNA editing before being transported to the 
cytoplasm where they are translated by the ribosome. Polyadenylation is an important RNA 
processing step where a long chain of adenine nucleotides is added to a messenger RNA 
(mRNA) molecule to increase the stability of the molecule, aiding its exportation from the 
nucleus to the cell cytosol. In this process, a series of repeated A nucleotides – poly-(A) tail – 
are added to the 3′ end of the pre-mRNA molecule. First, the 3' end of the transcript is 
cleaved and generate a 3' hydroxyl and poly-A polymerase (PAPs) adds a chain of adenine 
nucleotides up to 250 residues to the RNA. The poly-A tail provides stability of the RNA 
molecule and prevents its degradation.  
Furthermore, in the cell nucleus, the newly synthesized RNA molecules require extensive 
processing to become a functional RNA. In most eukaryotic genes, noncoding DNA is also 
found. 
 Such genes have split structures in which segments of coding sequence (called exons) 
are separated by noncoding sequences (intervening sequences, or introns). In the mRNA, the 
introns are then removed by splicing and yield a long RNA molecule which possess only 
exonic part. In a process designated by splicing, introns are removed from the mRNA 
molecule and then neighboring exons are stitched together. This process is exclusive of 
eukaryotic organisms.  
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 The mature RNA is then selectively transported from the nucleus to the cytoplasm 
where mRNAs are involved in the translation process, where the information in an mRNA 
molecule is converted into a protein. In this process, an mRNA molecule is used as a template 
by a ribosome, which will match each sequence of three nucleotides (codon) on the template 
mRNA chain with a sequence of three complementary nucleotides (anti-codon) on a tRNA 
molecule. Bearing in mind that each tRNA has connected to an amino acid that its anti-codon 
sequence calls for, this molecule will recognize and bind to a codon at one site and to an 
amino acid at another site of its surface. Thus, tRNAs function as translators between 
nucleotide sequences in RNAs and amino acid sequences in proteins. The ribosome, as the 
mRNA moves through it, covalently links each amino acid to the end of the growing 
polypeptide chain by peptide bonds. When the translation reaches a Stop codon, denoting the 
end of the protein, the completed protein chain and the mRNA molecule are released, and the 
ribosome is dissociated into two separated subunits.  
 Therefore, gene expression can be seen, as a mediator that interprets the genetic 
information of an organism (genotype) that gives rise to an outward physical manifestation 
(phenotype), via gene transcription and mRNA processing.  
2.3 Gene expression regulation: 
 Given that genes encode for proteins and proteins dictate the function of the cell and 
their structural proprieties. Each step of the gene expression is associated with the flow of 
information from DNA to RNA to protein that provides the cell with a probable control point 
for self-regulating that associated with its function. This allows cells to respond to maintain 
their cell-type specific expression patterns. 
In this way a cell can regulate the amount and type of proteins that it is manufacturing by 
several key factors:  
1. Required controlling when and how often a given set gene is transcribed;  
 2. To control processing of an RNA transcript; 
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 3. To select which mRNAs are exported from the nucleus to the cytosol; 
 4. Degradation of certain mRNA molecules; 
 5. Selecting for which mRNAs are translated by ribosomes; 
 6. Selectively activating or inactivating proteins after they have been synthesized; 
 7. Controlling of mRNA degradation. 
2.3.1 Transcriptional regulation 
 Transcriptional regulation plays a paramount role in controlling gene expression. 
During this process no, unnecessary intermediates are synthesized. This regulation can be 
executed at the promoter level by the association of TFs to the gene promoter region. As 
referred in section 2.2, the establishment of this connection will help to bind the RNA pol to 
initiate translation process. In the promoter region, nearly all genes are controlled by 
regulatory DNAs that may increase or decrease the activity of transcription of a certain gene. 
Now enhancers are sequence-specific TFs generally bind to these regulatory DNA regions 
and can control the switching on or off a gene, respectively. Often, the sequence specific 
factors and the general TFs accumulated in the promoter region and interacted via additional 
proteins named as co-factors. Rate of regulation of gene transcription is controlled by 
aiding/preventing the assembly of the general TFs and RNA pol at the promoter region 
(Kreimer and Pe’er, 2013). To bind the TFs and the RNA pol to the regulatory regions of the 
gene, the DNA chain needs to be accessible. 
Hence, the activity of transcriptional regulation can be also influenced by the level of DNA 
packaging. DNA is usually densely packed with histones, forming a closely packed structure 
called chromatin. Chromatin construction allows access of condensed genomic DNA to the 
regulatory transcription machinery proteins, and thereby controls the efficiency to initiate the 
transcription initiation. (Oberdoerffer et al., 2008). After transcription initiation, the activity 
rate of the RNA pol II enzyme is decreased and paused on a promoter proximal position. 
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From this stage, depending on the type of transcription elongation factor that interacts with 
the RNA pol II, transcription may halt or enter elongation phase (Dvir et al., 1997). 
2.3.2 Post-transcriptional regulation 
During RNA synthesis, post-transcriptional regulation controls the gene expression. 
 It contributes considerably to regulate gene expression across human tissues. The process of 
polyadenylation, introduced in section 2.2, influences the transcripts lifetime, protecting them 
from degradation and aiding their exportation to the cell cytosol.  
In a similar way, modulating the capping, splicing, addition of a Poly (A) tail where a 
modified guanine nucleotide cap is added to the 5′ end of pre-mRNA molecules is crucial for 
the novel transcript to exit the cell nucleus. Therefore, both these processes are essential for 
the stability of the mRNA molecule into an ideal time-window. The process of splicing, also 
referred in section 2.2, enables the production of mature messenger from a newly 
made precursor messenger RNA (pre-mRNA) transcript. During RNA splicing the introns are 
precisely excised and the exons are ligated together. The majority of nuclear pre-mRNA is 
spliced constitutively; that is, only one mature mRNA species is generated from a single pre-
mRNA in all tissues. In some cases, however, alternative 5′ and/ or 3′ splice sites are used 
during splicing, resulting in the production of more than one mRNA species from a single 
pre-mRNA. The production of different RNA products from a single product by changes in 
the usage of splicing junctions is known as alternative splicing. During this alternative 
splicing, the alternative 5′ and/or 3′ splice sites can result in structurally distinct mRNAs by 
either excluding potential exon sequences or incorporating otherwise noncoding introns 
sequences. 
2.3.3 Translational regulation 
Translation takes place in the cytoplasm. Some parts of the cytoplasm are so tightly 
packed with the soluble protein and cytoskeleton that ribosomes can be expected to have 
difficulties diffusing into them. This is usually performed by biding a repressor to the 5′ 
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untranslated region of the mRNA, which helps to guide the ribosome to the mRNA start 
codon. The ribosome is, thereby, kept from finding the translation start site. When conditions 
change, the cell can inactivate the repressor and increase translation of the mRNA. 
Regulation of the rate of protein synthesis is involved by the influencing the rate-limiting 
steps of the translational steps. Now, this process can be accomplished by the involvement of 
ribosomes or initiation factors. Generally, cytoplasmic mRNAs are actively translated by 
ribosomes to form messenger ribonuleoprotein particles, mRNP. Translational initiation 
process involved by utilizing two subunits: eIF2 and eIF4E. eIF4A, eIF4G and eIF4F are 
other subunits, involved in the initiation of translation process. In most cells, the availability 
of the eIF-4E which is a cap-binding protein is the rate-limiting factor involves initiating 
translation. Therefore, regulation of eIF-4E levels is important to control the rate of 
translation. 
2.3.4 Protein degradation 
Once protein synthesis is complete the level of expression of that protein can be 
reduced by protein degradation. Cells possess specialized pathways to degrade proteins, using 
enzymes designated by proteases. In these pathways, proteins which lifetime must be short, 
or which are damaged or misfolded are marked by the attachment of a small protein called 
ubiquitin. Ubiquitylated proteins are then recognized and destroyed. 
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CHAPTER 3 
GENE EXPRESSION ANALYSIS BY RNA-SEQUENCING DATA 
3.1 Approaches for genome-wide expression analysis: 
It is worth mentioning that high-throughput sequencing becoming a prime choice to 
measure the gene expression to get an insight about the transcriptional behavior of biological 
systems.  Therefore, identification of differential gene is an important paradigm that is used 
in many areas of biology and medicine. It can be employed to identify significantly 
differentially expressed genes between two or more biological conditions of interest (Schena 
et al., 1995). To classify heterogeneous diseases such as cancer, differentially gene 
expression analysis plays a pivotal role (Bhattacharjee et al., 2001). This analysis is also 
important to understand the relation between genes profile and survival or tumor 
aggressiveness (Veer et al., 2002). To discover new drugs (Pagliarulo et al., 2002), diagnose 
diseases (Heller et al., 1997), differentially gene expression is important (Thiery et al., 2006). 
 Gene expression analysis can be divided into two parts namely genome-wide and 
target-based approach, depending on what it is anticipated to study. In the absence of any key 
genes of interest, the data is acquired at the biological system level. Therefore genome-wide 
approaches such as microarrays (Augenlicht and Kobrin, 1982) or RNA-Seq (Mortazavi A et 
al., 2008) technologies have emerged as a powerful technology for the detection of 
differential gene expression, that enables to quantify the frequency of RNA species in a 
certain biological system. Transcriptome profiling which is defined by the complete set of 
transcripts in a cell and their amount at a definite acquisition point is the main approach to 
measure the differential gene expression. As stated in section 2.2, knowledge of the 
transcriptome is very useful to provide a link between change of expression of a gene and 
their phenotype presented by the cell (Wang et al., 2009). On the contrary, polymerase chain 
reaction (qPCR) should be employed when the genes of interest are already known (Murphy 
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L D et al., 1990). The main purpose of this reaction is to perform the gene expression 
analysis. Here I have mainly focused on genome-wide GEA, particularly those using RNA-
Seq technology and explain the pros and cons associated with this analysis. Furthermore, I 
will also include the brief RNA-Seq protocol and revisit the current methodologies which are 
associated to assess from the raw nucleotides sequence and their active cellular processes 
upon collection of the transcriptome. 
 To perform transcriptomics analysis an ample number of technologies have been 
developed over the years. Out of all these methods, High-throughput sequencing technology 
has endowed with an unprecedented aspect about the transcriptional landscape of an 
organism and becoming the paradigm to measure RNA expression levels. With the dawn of 
sequencing technology, it’s now feasible to profile gene expression levels in every field in 
life sciences and becoming prevailing technique for clinical use. Generally, one of the main 
goals of this experiment is to identify the differential gene expression, gene isoform, post 
transcriptional modifications and so on to understand phenotypic variation (Rapaport et al., 
2015).   
Understanding the large-scale studies of gene expression levels, a microarray was a 
tool to detect the gene expression in the 1990s. Concurrently, the process of measuring the 
gene expression, microarray can provide a picturesque of transcriptional activity in a wide 
range of biological problems, including identification of differentially expressed genes 
between diseased and healthy tissue (Zhao et al., 2014). Currently, DNA microarrays are a 
relatively inexpensive and can afford many laboratories for transcript profiling. In 
microarray, a short single stranded DNA molecule, called probes, are attached to fixed 
locations on a solid substrate. Then RNA molecules (transcriptome) are extracted from the 
sample and copied into complementary DNA (cDNA) with the help of reverse transcriptase. 
Fluorescent dye was used to label in the cDNA. Finally, cDNA is passed over the solid 
support and complementary sequence will tend to hybridize. Then expression is quantified by 
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using a fluorescence scanner that measures the amount of fluorescence coming from each 
probe on the slide (Hoheisel, 2006). 
In biological samples, gene expression microarray profiling endowed with precise 
determination of expression levels of genes in a single hybridization experiment. 
Identification of nearly 57000 citations by using a simple search for the term “microarray” in 
PubMed database shows its consequence for assaying gene expression. However, the power 
of this technology has several drawbacks. For instance, due to cross-hybridization, the 
expression measurements have high background levels. Therefore, the probe sequences must 
be pre-specified so that priori the sequences can be identified. Additionally, due to both 
background and saturation signals, the accuracy of measurement of expression is limited 
(Okoniewski and Miller, 2006). In order to overcome this limitation probes should be used 
that can differ in their hybridization properties. Otherwise it is unreliable to compare the 
same array between different genes (Gautier et al., 2004). Therefore, it’s crucial to maintain 
the experimental design to perform successful microarray experiment. In order to perform 
successful experiment, sometimes a major question whether the microarray experiment 
should be performed using the single-color or two-color to compare the relative gene 
expression. Until date lot of articles have been published reading this issue saying that single-
color arrays are more flexible in analysis compare to the two-color. Anyway, in contrast to 
the microarray technology, some sequence-based methods are also important to determine the 
cDNA sequence. Previously, Sanger sequencing was performed to determine the cDNA 
sequence (Sanger et al., 2004). However, Sanger sequencing is expensive and have relatively 
low throughput and generally is not quantitative (Wang et al., 2009). To overcome these 
limitations, tag-based methods were developed namely serial analysis of gene expression 
(SAGE) (Velculescu et al., 1995), cap analysis of gene expression (CAGE) (Shiraki et al., 
2003) and massively parallel signature sequencing (MPSS) (Brenner et al., 2000). However, 
SAGE based technology doesn’t measure the actual expression level of a gene. During SAGE 
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analysis, short tag (ten bases) has been produced, makes the analysis hard to assign a tag to a 
specific transcript with accuracy because these short tags can be mapped to more than one 
place in the reference genome, allowing an ambiguous identification of transcripts. 
Sometimes, same tag possesses with the two different genes and the alternatively spliced 
gene could have different tags at 3′ ends.  
Finally, with an emergence of high-throughput sequencing technologies have 
overcome the limitations of both microarrays and tag-based methodologies (Church, 2006). 
Specially, RNA-Seq is a transcriptome profiling technology and NGS platform for 
differential gene expression (Mardis, 2008). Particularly, RNA-Seq technology is more 
reliable to arrays and employed for both mapping and quantifying transcriptome across all 
cell types, perturbation and states (Roberts et al., 2011). RNA-Seq technology is more 
persuasive and quantifies the expression of novel transcript over a wider dynamic range 
which is not possible to quantify in array-based technology (Marioni et al., 2008). Due to 
hybridization-free approach, this technique has been widely used in an integral part of 
microbiological research (Mardis, 2008). Additionally, RNA-Seq technology can be used to 
detect of gene fusion events (Maher et al., 2009), detection of single nucleotide 
polymorphisms (Mardis, 2008), investigation of post transcriptional RNA mutations (Garcion 
et al., 2004), study of alternative splicing events (Pan et al., 2008), discovery of novel 
transcripts (Guttman et al., 2010; Degner et al., 2009). Of course, in near future, the probable 
technical goal is to sequence and count entire mRNA molecules known as single-molecule 
sequencing which enable to quantify even single cells.  
3.2 RNA-Sequencing experiment workflow 
 In all living organisms, RNA molecules are crucial components and several high-
throughput sequencing techniques are existing to interrogate of RNA sequences on a large 
scale. Currently, 454 GS-FLX from Roche 454 Life Science, Genome Analyzer II from 
Illumina, Inc. and AB SOLiD from Applied Biosystems are believed to be the foremost 
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method in expression analysis. However, different technologies require different 
experimental procedures for sequencing study. In principle, any high-throughput sequencing 
technology can be used for the RNA-Seq study and Illumina’s machines have already been 
applied for the purpose (Bennett, 2004). In RNA-Seq study, after conversion to a library of 
cDNA fragments with adapters attached to one or both ends and sequenced in a high-
throughput way to get the short reads (Wang et al., 2009). The resulting reads are either 
mapped to a reference genome or de novo without genomic sequence to get the genome-scale 
landscape of transcriptional or post-transcriptional gene expression.  
 Now, RNA-Seq faces several technological challenges like other high-throughput 
sequencing technology such as data storage capacity, process large amounts of data. 
Therefore, these challenges should be overcome to reduce errors by removing low-quality 
reads, improvement in base-calling. Despite the challenges, RNA-Seq has facilitated us to 
make an unprecedented large-scale overview of the transcriptome. Keeping in mind, RNA-
Seq revealed many novel transcribed regions, splicing isoform for many genes. In this thesis, 
I have mainly focused on the pipeline which is appropriate for NGS data generated from the 
Illumina platform. Additionally, I have also described the details analysis which I have 
performed through the pipeline. Particularly, the approach of sequencing in the Illumina 
machine comprises the following fundamental steps: 
1) Informative RNA enrichment 
An archetypal RNA-Seq experiment begins by purifying a subset of RNAs from the 
total RNA to analysis of transcriptome expression. Particularly, for protein coding RNAs, this 
enrichment analysis is carried out by selecting poly(A)+ molecules using oligo-dT associated 
with magnetic or cellulose beads. It is worth mentioning that prokaryotic mRNAs, poly(A)-
transcripts in eukaryotic cells are frequently subject to exploration (Hrdlickova et al., 2017). 
Additionally, in cells the most abundant RNA is rRNA, >90% present in cells consists on 
rRNA (Wilhelm and Landry, 2009) and need to be depleted due to small interest in most 
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studies (Tariq et al., 2011). Though, varieties of selection processes have been developed 
recently for rRNA depletion, oligo-dT based purification of poly (A)+ RNA is the prime 
method that ensures to get a strong signal for the RNA population of interest. 
2) RNA fragmentation 
Still now, RNA fragmentation is the most commonly used technique in RNA-Seq 
library preparation. Before reverse transcription (RT) process, RNA samples are subjected to 
fragmentation process to get a certain size range. This fragmentation process happened after 
selection of poly (A)+ or rRNA depletion. Due to the limitations of the size, fragmentation 
process is mandatory in the most sequencing platforms. After purification, the larger RNAs 
are fragmented by using RNA hydrolysis or nebulisation. On the other hand, full length 
double-stranded cDNA can be fragmented by DNaseI treatment or sonication. Now cDNA 
fragmentation is more likely towards the 3′ end of the transcript.  
3) Synthesis of double stranded cDNA 
In RNA-Seq, sequencing of poly (A) RNAs is the most common application unless a 
very small amount of RNA is accessible. In eukaryotes, most protein-coding RNAs contain 
poly (A) tail. The RNA fragments are converted into cDNAs using reverse transcriptase 
enzyme which requires the hybridization of primers into the RNA chain. These primers can 
be oligo-dT or sequence of random primers. For most protein-coding RNAs (mRNAs) and 
many long noncoding RNAs (lncRNAs), it is not advisable to use the oligo-dT primers due 
it’s biasness on the 3′ of the transcript. As a result, the sequencing reads will be enriched for 
the 3′ ends of the transcript (Wilhelm and Landry, 2009). Therefore, random primers are 
preferred to use which have the potential hybridization capacity to random sites of the RNA 
molecule. Finally, after synthesizing the first strand of cDNA, the RNA template is 
eliminated and generated a second cDNA by using DNA pol I and finally a double stranded 
cDNA molecule is generated. Therefore, poly (A) purification is a preferred method to select 
poly(A) + RNA.  
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4) Adapters ligation 
In a benchmark of RNA-Seq library etiquette, a desired size of cDNAs has been generated 
through reverse transcription (RT) of fragmented RNAs with random hexamer primers. 
Before amplification and sequencing process, a required extent of cDNAs has been also 
generated based on the fragmentation of full-length cDNAs that are ligated to DNA adapters.  
During adapter ligation process, 3′ of the cDNA overhangs are switched into blunt ends by a 
specialized enzyme. Next a series of 3′ ligations occurred by using a truncated RNA ligase II 
whereas 5′ adapter ligation happened by using RNA ligase I (Hrdlickova et al., 2017). In 
order for ligation, the cDNA fragments to the adapter, an A base is added to the 3′ depleted 
end which contain a single T base over-hanged at their 3′ end. Finally, distinctive adapters are 
ligated to each strand of 3′ ends of the double-ended cDNA.  
5) Size selection and PCR amplification 
During fragmentation step, DNA molecules are divided into two different sizes. By 
gel extraction, a desired range of DNA length is purified to ensure that all molecules are of 
similar length. Furthermore, this procedure eliminates unligated adapters as well as those 
ligated to one another. Finally, two primers are annealed to the adaptors tail followed by 
amplification by PCR of the purified cDNA. 
6) Cluster generation 
Inside the flow cell, single-stranded DNA templates are bridged-amplified to form 
clonal clusters prior sequencing. During the PCR amplification, the double stranded 
molecules need to be denatured into single strands molecules. Subsequently, by using the 
high density of immobilized forward and reverse primers, the DNA templates are hybridized 
to a slide. Now, DNA polymerase is used to copy the templates from the hybridized primers. 
After the denaturation, the original templates disappear the copies immobilized on the flow 
cell surface. After fixation process, the immobilized copies are hybridized to adjoining 
primers. Then DNA polymerase copied the templates and finally formed double stranded 
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DNA bridges which in turn are denatured and formed two single-stranded DNA templates. 
Finally, using the base cleavage the reverse DNA strand is removed and the immobilized 3′-
ends of the forward strand are prohibited to prevent interference in the sequencing process. 
This procedure is repeated to create a dense clonal cluster that contains at least 1000 
molecules per cluster. 
7) Sequencing-by-synthesis 
High throughput sequencing has been started with the sequencing hybridization 
primers which added each single-stranded molecule in the clusters. Then DNA-templates are 
simultaneously reversing complemented by using fluorescent-labeled nucleotides. After 
addition of nucleotide, clusters are excited by a laser which causes fluorescence at the last 
integrated base. The cycle is repeated to remove the fluorescent dye and blocking group. The 
cycle is generated a sequence of images, containing new incorporated nucleotide where the 
fluorescence labeled signal of each cluster is captured. As a result, the color of the lighted 
spot represents a different base type. Then a sequence of nucleotide for each cluster can be 
obtained by combining the attaining the sequence of images. Finally, this information is 
saved in a text file named as FASTQ file format. FASTQ file contains a unique ID to identify 
the read, the sequence of nucleotides and the quality scores. Due to the ubiquitous nature in 
illumina, FASTQ format has become de facto for NGS analysis. Now to understand the read 
quality at each base is defined by the Phred score that can range from 0 to 60 on a logarithmic 
scale. The Phred quality score is defined as Q=-10log(e).  
NGS can read sequence from both ends of a single DNA and generate “pair-end 
reads”. FASTQ files are always pre-processed to check the quality controls and remove any 
adapters in the sample preparation process. Sometimes contamination can be detected by the 
distribution of k-mers which help to detect the contamination. These all help to detect the 
potential pitfalls before the downstream analysis.   
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3.3 Quality control of sequencing reads 
 Next-generation sequencing (NGS) technologies have drastically broaden the area of 
genomic research. High-throughput sequencing technology can generate enormous amounts 
of data in a single sequencing run. To extract biological conclusions by analyzing acquired 
sequence, it is important to assess the library quality as well as the sequencing performance. 
Therefore, for any alignment process, the low quality of reads should be removed (Levin et 
al., 2010). Due to a range of artifacts generated during library preparation, NGS can be 
adversely affected the downstream analyses. 
Until recently, to highlight the quality score of the NGS data, several software tools 
have been developed. Contamination with adapter sequences and biases in base composition 
are the primary reason to generate the low-quality base (Trivedi et al., 2014). To assess the 
quality of the raw reads generated by the sequencing platform is the foremost step of the 
quality control (QC) process and FastQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc) is a popular tool for this analysis. 
In NGS platform, FastQC is useful for considering the overall quality score of a sequencing 
run and commonly used as an initial QC checkpoint. Given a set of raw sequencing reads, the 
main aim of quality control (QC) is to align the reads to a reference genome and consider the 
quality of the alignments. The quality of alignments can be obtained by several metrics such 
as depth of coverage, contamination of rRNA, continuity of coverage, and GC bias 
(Andrews, 2010). The main purpose of performing quality control is to process raw sequence 
data coming from high throughput sequencing prior to aligning against a reference genome. 
Now to evaluate the quality of the high throughput sequencing reads, some valuable 
information needed to be extracted from the variation of the Phred quality score (Q score) of 
a sequencing platform (Yang et al., 2013). The content of bases has very little difference 
between different bases during sequencing. Now the number of bases added when the 
21 
 
sequencer is unable to produce any base call with enough confidence of reads length (Ewing 
et al., 1998). 
Based on this type of analysis, the low sequencing quality bases should be eliminated 
to ensure the quality of the high throughput data. From the high throughput sequencing, the 
cellular activity is characterized and going to be extracted the biological conclusions. 
3.4 Mapping reads 
After removal of abnormal reads from the raw cDNA sequence reads, it is mandatory 
for the short sequenced to be mapped to a reference genome or transcriptome. The main goal 
of this step is to find the genomic location of each transcript sequence on a given reference 
genome. According to Fonseca et al. this problem can be achieved by computationally 
(Fonseca et al., 2001). This helps to match the reads with the reference genome and this can 
be challenging because sequencing generated millions of short reads that needed to be 
mapped to reference genomes that usually very large. So, it is important that mapping 
algorithms needed to be extraordinarily competent and used processors and memory in a 
most advantageous way. Moreover, 50% repetitive sequences present in complex organisms 
such as human or mouse genome, so it is another challenging aspect in next-generation 
sequencing that needed to be handled. Therefore, mapping tools are required to handle this 
multiple mapping locations (Fonseca et al., 2001).  
 
Figure 3.1. Mapping of a paired-end read with different reference files: genome and transcriptome. Adapted 
from Trapnell and Salzberg, Figure 2 (2009).  
Sometimes, aligning reads against the reference genome is slower because it considers 
all non-coding positions. Currently, several alignment programs are available to handle 
spliced alignments, including TopHat2 (Kim et al., 2013), SOAPSplice (Huang et al., 2011), 
Exon A Exon B Exon A Exon B Exon C
Spliced alignment
(a) Alignment of a paired-end read to the 
genome. The read needs to be mapped across 
introns (spliced alignment)
(b) Alignment of a paired-end read to the 
transcriptome
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Blat (Kent, 2002) or Exonerate (Slater and Birney, 2005). On the other hand, Bowtie 2 
(Langmead and Salzberg, 2012), BWA (Li and Durbin, 2009), MAQ (Li et al., 2008) or 
SOAP2 (Li et al., 2009) are specialized for aligning short reads to a reference genome. 
In computational biology, Bowtie 2 is used as short-read mappers that can able to 
index a file and speeded up the mapping process. This mapping process allows an efficient 
and relatively small memory (Langmead and Salzberg, 2012). Particularly, Bowtie 2 indices 
are based on the Burrows-Wheeler Transform (BWT) that helps to keep the memory low 
(Kent, 2002). In human genome, this transformation keeps the memory to fit in 3.5 gigabytes. 
The alignment process is extracted raw NGS read which are likely to be matched in the 
genome with the Burrows-Wheeler Transform (BWT) based methodology (Burrows and 
Wheeler, 1994). Finally, each aligned character slender the list of possible mapping or 
genomic positions. Sometimes seed placement will be prioritized if Bowtie 2 cannot find a 
location where the read align perfectly (Langmead and Salzberg, 2012). Using the Single 
Instruction Multiple Data (SIMD)-accelerated dynamic programming algorithm, we can 
check whether sufficient numbers of alignments are examined (Slater and Birney, 2005; 
Trapnell and Salzberg, 2009; Langmead et al., 2009). 
The output file from the mapping is a SAM format file. SAM file contains all the 
information of overlapped and non-overlapped reads. Particularly, overlapped reads contains 
the information about the genome location where the read was mapped and it’s respective 
score (Li et al., 2009). 
3.5 Expression quantification and normalization 
During mapping of the RNA-Seq reads, it’s needed to convert the data into a 
quantitative measure of gene expression. Several approaches are available now-a-days, but in 
this problem, the easiest approach is adding up the number of reads which lie within the 
location of each element (Van Verk et al., 2013; Wilhelm and Landry, 2009). It is easy to 
extract this information if reads were overlapped to the transcriptome otherwise gene 
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expression measurement can be performed by using Cufflinks package if reads were aligned 
to the genome (Trapnell et al., 2012). In RNA-Seq, estimation of gene/transcript expression is 
predominantly relying on the no. of reads that aligned to each transcript sequence. There are 
several algorithms available recently for transcript/gene mapping. One such algorithm known 
as Sailfish that mainly depends on the on k-mer read counting without the need for mapping 
(Conesa et al., 2016). However, gene expression measurement can be quantified by using 
HTSeq package that enable aligned reads to the genome (Anders et al., 2015). This 
quantification process uses GTF file that contains genome coordinates of exons and genes. 
Now to compare the expression levels among samples, transcript length, and total number of 
reads affect read count.  
 
To remove this biasness, RPKM (reads per kilobase of exon model per million reads) 
normalizes a transcript’s read by both its length and the total number of reads mapped in the 
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Fig 3.2. An overview of the tuxedo protocol. The assembly and characterization of expressed genes
from the experimental data, statistical analysis of differential gene expression. QC study is performed in
the raw RNA-Seq reads using FastQC; the filtered reads are then mapped to a reference file using
Bowtie 2; from this data is measured the gene expression level and performed a differential expression
test by Cuffdiff; the genes are then concatenated into GO terms using GOStats. In the end, this will give
insight into the biological processes that are differentially active between the conditions in comparison.
Adapted from Trapnell et al., Figure 2 (2012).
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sample to remove the feature-length and library-size effects. FPKM (fragments per kilobase 
of exon model per million mapped reads) normalized paired-end data (Mortazavi et al., 
2008). During the RNA-Seq experiment, two conditions will be examined where reads are 
first mapped to the genome with TopHat. These mapped reads are fed to Cufflinks, which 
produces one file of assembled transfrags for each replicate. Finally, Cuffdiff analysis 
performed to get the differential gene expression analysis. These files are visualized with 
CummeRbund to facilitate exploration of genes identified by Cuffdiff as differentially 
expressed, spliced, or transcriptionally regulated genes as it can be seen in figure 3.5.  
To estimate transcript-level expression several sophisticated algorithms have been 
developed recently. Cufflinks approximate transcript level expression from a genome 
mapping by using a TopHat. Cufflinks use GTF information to identify differentially 
expressed transcripts. RSEM (RNA-Seq by Expectation Maximization) (Li and Dewey, 
2011), eXpress (Forster et al., 2013) algorithms have been used to normalize within the 
sample to correct the sequencing biasness which quantify the expression from transcriptome 
(Finotello et al., 2014). 
3.6 Differential expression  
After quantification and normalization, statistical testing usually performed between 
conditions. Due to count-based nature of RNA-Seq data, Poisson distribution provides a good 
fit for counts arising from technical replicates, has been performed (Marioni et al., 2008). 
According to Leek et al. (Langmead et al., 2010) and Smyth et al. (Robinson and Smyth, 
2007) these distributions do not account for biological variability across samples. Because 
Poisson’s distribution accounts for the variance which is associated with the biological 
replicates and will be prone to high false discovery rate (FDR). FDR arises from the 
underestimation of sampling error (Robinson and Smyth, 2008). To overcome this limitation, 
recently many methods were developed that measure the statistical significance in a dataset 
with a low number of biological replicates. Cuffdiff finds differentially expressed genes and 
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transcripts that are transcriptionally and post-transcriptionally regulated and groups 
transcripts into biologically meaningful groups (Trapnell et al., 2012). In Cuffdiff, it is 
assuming that the number of reads produced by each transcript is proportional to its 
abundance (Trapnell et al., 2012). In RNA-Seq, presence of large number of technical 
variabilities arises during library preparation and in the same experiment, variation of 
biological replicates sometimes fluctuates changes in expression. Even though it’s 
exceptional level of accuracy, RNA-Seq has sources of bias during the gene expression 
analysis. However, Cuffdiff can automatically eliminate a large fraction of the bias in RNA-
Seq read distribution across each transcript and improves its abundance estimates. RNA-Seq 
has less technical variance compared to micro-arrays (Zhao et al., 2014). During sequencing, 
Cuffdiff provided multiple technical or biological replicate in sequencing libraries per 
condition and will help how read counts vary for each gene across the replicates. These 
variances calculate the significance of observed changes in expression (Trapnell et al., 2012). 
In cuffdiff, user can fed two or more SAM/BAM files, generated from TopHat alignment, as 
well as a GTF file that contains transcript annotations as input. As an output file, Cuffdiff 
reports numerous files that contain the results of DEG analysis. User can download and can 
be viewed with any spreadsheet application (such as Microsoft Excel). These files contain 
fold change in log2 scale, P values, q value and gene/transcript name and location in the 
genome (Trapnell et al., 2012). During differential gene expression analysis, Cuffdiff identify 
genes that are differentially spliced or regulated via promoter switching. In a gene, Cuffdiff 
groups together isoforms that have the same TSS which are all derived from the same pre-
mRNA. Cuffdiff also calculates the total expression level of a TSS group by summing up the 
expression levels of the isoforms. Due to the presence multiple TSSs in a gene, Cuffdiff is 
also looking for changes in expression between TSS in different conditions.  
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3.7 Pathway analysis 
Being a knowledge-driven quality, biologists are facing everyday how to interpret large-scale 
data especially with the emergence of high-throughput technology. The limitation usually lies 
to understand the meaning of array of genes to divulge the underlying molecular mechanism 
of the phenotype. Finally, list of differentially expressed genes can be grouped into common 
pathways; enable to identify differentially expressed pathways. The purpose of this pathway 
enrichment analysis is to find ultimate possibilities of the hidden connections of molecular 
information (transcriptome) with the phenotype of an organism in study (Emmert-Streib and 
Glazko, 2011). For individual genes, the variation in gene expression depends upon a certain 
disease that could be only moderate or even negligible. The pathway enrichment analysis of 
set of genes variation can evidence differences between different phenotypes (Mootha et al., 
2003) and evaluates the function of differentially expressed genes and executes different 
cellular pathways and this pathway knowledge available in public repositories such as the 
Gene Ontology (GO) (Ashburner et al., 2000) and the Kyoto Encyclopedia of Genes and 
Genomes (KEGG) (Kanehisa et al., 2012). The pathway information concatenates into these 
databases with the gene expression patterns, resulting in the transformation of the array of 
individual gene identification into these pathways. According to Khatri et al. pathway 
analysis is performed based on overrepresentation analysis (ORA) and usually provided as an 
input a preselected differential expressed gene list (Khatri et al., 2012; Huang et al., 2009). 
This preselected list of genes will be taken from the output of cuffdiff analysis which has 
with higher rates of under- or over-expression with a certain FDR. A test is executed to 
ensure if the lists of gene have any biological function in general also involved in the same 
cellular process (Trapnell et al., 2009). The most commonly used tests are Fisher’s exact test 
(Evangelou et al., 2012), hypergeometric (Zeeberg et al., 2003), chi-square (Falcon, and 
Gentleman, 2007), or binomial distribution. An extensive list of tools that are designed to 
perform this type of analysis is introduced by Lempick et al. (Zhong et al., 2004). 
27 
 
CHAPTER 4 
METHODS 
4.1. Tailor pipeline: 
Over the past few years, ample amounts of methods had been developed to deal with different 
aspects of RNA-Seq data analysis. However, it was required to combine several bespoke 
methods to address the needs and specificities of each problem and sometimes this 
combination is not a simple challenge. Therefore, special awareness must be taken to prevent 
erroneous biological conclusions.  
With these considerations in mind, we proposed a sequence of tools (pipeline) which 
is suitable to perform a comparative study between RNA-Seq samples. The pipeline referred 
as “Tailor Pipeline” which can able to able to take from raw RNA-Seq reads, to extract the 
main biological processes differing between the analyzed conditions as it can be seen in 
figure 4.1.  
 
The pipeline has a broad interest because sometimes biologists interested to perform a 
comparative analysis, on the bench, under different environments, cells are treated with 
different pathogenic agents. Frequently, the best-chosen approach is the sequencing of the 
Figure 4.1. Schematic representation of the Tailor_Pipeline used in the RNA-Seq data. The raw
.Bcl file has been submitted in the GHPCC cluster and performed differential gene expression analysis
by using TopHat, Cufflinks, and Cuffdiff. Gene set enrichment analysis performed to identify the
differentially regulated BPs, CCs and MFs and visualize the most differentially expressed pathways.
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cell transcriptome by using high-throughput sequencing, next-generation sequencing 
techniques (Shendure and Ji, 2008). However, the next-generation technologies generated, 
routinely, a dozen of gigabytes of data. Now, to extract relevant biological information from 
it, the computational power is essential. For that reason, this pipeline will provide all the 
necessary information which is required to solve any biological problem. The details result of 
this pipeline described in the subsequent chapters of this thesis. 
A diagram illustrating the conceived pipeline is showed in Figure 4.1. This pipeline 
was implemented in a Tailor_file and incorporates both publicly available tools and scripts 
developed by Riley lab group members to perform the biological evaluation of the RNA-Seq 
data.  
Data analysis begins with the input of the raw read files and the reference files. Once 
this data is gathered, reads are processed with FastQC (Trapnell 2004). FastQC consists of 
Java software which provides tools to perform a QC study in raw high throughput sequencing 
data. The analysis performed by this tool ensures that the data is qualitatively good and there 
are no problems or biases in it and reported per base sequence quality, per sequence quality 
scores, per base sequence content, per base GC content, per base N content, sequence length 
distribution, sequence duplication levels, overrepresented sequences and Kmer content. 
Sometimes, sequencer and the starting library materials may create some problem which can 
be easily detected by a QC analysis. Some abnormalities may be resolved by trimming base 
pairs from the raw read. The pipeline contains a script that can trim a given number of base 
pairs during this analysis. The pipeline is pre-set not to trim any bases from the raw 
nucleotide sequence. However, this option can be modified in the Tailor_file, depending on 
the QC results.  
Afterwards, trimming, reads will be aligned with a reference sequence using Bowtie 
2, a well-established mapper (Langmead and Salzberg, 2012). In RNA-Sequencing 
technology Bowtie2 is a fast and memory-efficient mapping tool that is particularly suitable 
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for the alignment of small reads, to the respected genome reference. In our analysis we have 
used the human and mouse genome respectively. Previously to the mapping process, the 
reference file must be indexed to be used by Bowtie2. To perform this task, bowtie2-build is 
used. This tool constructs a Bowtie index from the set of DNA sequences in the reference 
file, which usually is in the FASTA format (Langmead 2010). Once the index is built, Bowtie 
no longer uses the original FASTA sequence. At this point, a set of options associated with 
the type of search performed by the Bowtie 2 algorithm need to be defined. The output of the 
mapping process is a Sequence Alignment/Map (SAM) file which stores the information 
about the read alignments against the reference sequence. Particularly, for paired-end reads 
two records are printed (i.e. two lines of output) describing the mapping proprieties for each 
comparison (Li 2009).  
Typically, after mapping RNA-Seq reads to a reference genome, the number of reads 
that map a certain gene or transcript is measured. The read counts have been found to be 
roughly linearly related to the abundance of the target transcript (Mortazavi 2008). To get the 
gene expression information, the pipeline uses TopHat, a script integrated in the TopHat 
package that counts how many reads map to a certain feature (Kim 2013). Due to the nature 
of this study, where high-level pathway enrichment analysis was the goal, it was not relevant 
to consider multiple isoforms of the same gene. To perform the count of the mapping reads, a 
reference genome file is required that contains information about the features.  
Next differential expression analysis was performed between the RNA-Seq samples to 
detect differentially expressed genes among the conditions in study and differential gene 
expression analysis has been done by using Cuffdiff (Trapnell 2012), that takes the output 
files from TopHat or another read aligner. This output files are two or more fragment 
alignment SAM/BAM files, as well as a merged.gtf from the output of Cuffmerge as input 
(Trapnell 2012). Cuffdiff tests the observed log fold change in transcripts expression against 
the null hypothesis of no change and produces several output files for changes in expression 
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at the transcript level, primary transcripts, and genes. To use multiple conditions, users must 
specify multiple replicates by feeding in the associated BAM files for each condition. For 
each gene, the output table contains information about the mean gene expression level, the 
fold change from the first to the second condition, the logarithm (to basis 2) of the fold 
change, the p-value for statistical significance of this change and the p-value adjusted with 
Benjamini-Hochberg procedure (Benjamini and Hochberg, 1995) that controls the percentage 
of false positives among all the rejected hypotheses (FDR).  
To select the significant differentially expressed genes, the algorithm is pre-set to 
perform a trimming based on the raw output table by selecting only p-value less than 0.1. To 
understand this trimming, it was necessary to have a clear knowledge about which statistical 
measure the p-value translates provided the null hypothesis is true. This null hypothesis refers 
to a general or default position and it was rejected if the p-value is less than a significance 
level. In differential gene expression analysis, the null hypothesis corresponds to a scenario in 
which the genes were not significantly differentially expressed. This means that lower p-
values was unlikely that the observed difference was occurring randomly and, thereby, the 
0.1 p-value cut-off assures that only the statistically important entries will be considered for 
further analysis.  
Lastly, the genes found to be differentially expressed are associated with GO terms 
using a Bioconductor package called GOStats (Gentleman and Falcon, 2013). GOStats used a 
hypergeometric test to relate a given gene list with the standardized controlled vocabulary in 
the GO database. Particularly, it consists in three structured controlled vocabularies: 
biological processes (BP), sets of molecular events which are essential to the functioning of 
integrated living units; cellular components (CC), parts of cells or its extracellular 
environment; and molecular functions (MF), elemental activities of a gene product at 
molecular level (Ashburner 2000). In the final step, it is possible to have a biological insight 
about the samples being compared. Based on the output table user can able to conclude the 
31 
 
most significantly differentially expressed active processes when the cell is subjected to 
different biological conditions. To perform an analysis using the Hypergeometric-based test 
implemented in the GOStats package, the pre-set universe is contained a genome wide 
annotation database for Homo sapiens, mouse and others those are mapped with Entrez Gene 
identifiers. The pipeline is adjusted to analyze any species RNA-Seq data. Secondly, it is 
necessary to define a list of genes for the analysis and this list corresponds to the collection of 
genes in the final table of the differential expression analysis step. For the entries generated 
through the hypergeometric test, it is defined a p-value cut-off of 0.1. Additionally, the test 
direction is set as over, so the result of this step will be a table with the over represented GO 
terms associated with the differentially expressed genes found in the previous pipeline step 
for each one of the ontologies. In other words, GOStats will identify most important ontology 
terms that differ between the conditions being compared in the cuffdiff analysis.  
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CHAPTER 5 
RESULTS 
Part-1: Diet induced SAMP6 mice results 
5.1. Dataset Description 
In this study SAMP6 strain mouse were used and colonies taken from eight females 
and four males. For 25 mice each SAMP6 and AKR/J were fed with high fat diet (HFD). 
Generally, the age of those mice is 6–8 weeks of age. High-fat diet contains fat, protein, and 
carbohydrates and low-fat diet (LFD) contains fat, protein, and carbohydrates. In HFD, 60% 
calories are coming from fat whereas in LFD, 10.2% calories are coming from fat. This 
feeding process continues for 6 months where mice were fed daily with fresh high, low-fat. 
Subsequently Mice were sacrificed, and RNA has been extracted by using TRIZOL reagent. 
Then, two treated, HFD and LFD, SAMP6 mice were used in biological triplicates for library 
preparation. All RNA samples are DNAse treated and used to create single indexed (6 base 
pairs) RNA-Seq libraries by using TruSeq RNA preparation kit according to the 
manufacturer’s protocol [96]. All sequencing has been done by using the Illumina HiSeqTM 
2500 instrument. HiSeqTM 2500 was used to sequence RNA-Seq libraries that have been 
loaded with software version 3. Then performed 51-cycle paired-end run of the single 
indexed RNA-Seq libraries and demultiplexing has been done by using the raw bcl base call 
files upon completion. Based on that RNA-Seq dataset has been created from SAMP6 
background strain mice that were fed regular low-fat and high diet (Table-5.1).  
 
Table 5.1. Data set of diet induced mice study. The experimental data is composed 3 biological replicates for 
each of the 2 different conditions. 3 high fat and 3 low-fat diet mice were used for this experiment.  
High fat mice Low fat mice
NK001_1_CGATGT NK004_4_GCCAAT
NK002_2_TGACCA NK005_5_CAGATC
NK003_3_ACAGTG NK006_6_CCTGTA
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The Tailor pipeline was used to process the experimental data characterized above. In the 
subsequent section I have described the results from each processing step, interpret them and 
ultimately, conclude about which are the up- and down- regulated pathways in diet induced 
SAMP6 mice that associated with fibrosis. 
5.2. Differential Gene Expression 
Overall, the quality of the HF-SAMP6-over-LF-SAMP6 RNA-Seq data was high. 
Nevertheless, the quality modules would generate warnings. Those inadvertences appeared 
on per base sequence content, on the per base GC content and on the Sequence Duplication 
levels sections. Particularly, the first warning topic plots out the proportion of the four DNA 
bases for each base position in a sequence file. These properties were not verified for any of 
the analyzed read files. In fact, all of them had a high variability on the first 15 bases, which 
pointed out to the presence of an overrepresented sequence in the library. This may be related 
with a problem in the library generation or can be a consequence of an abnormal sequencing 
process. However, the most plausible explanation was the use of random hexamer priming to 
introduce biases at the start of sequencing reads, as described by Hansen et al., 2010 (Hansen 
2010). Based on this study, 15 bases were trimmed from the beginning of each original 
sequence. Given that the reads are long (90 base pairs); the loss of information inherent with 
this trimming is not significant. Therefore, each one of the reads is composed, after this step, 
by 75 base pairs. 
 The filtered HF-SAMP6-over-LF-SAMP6 reads were then mapped against a 
reference mouse genome (mm10) file. The reference file was downloaded from Ensemble 
website and contains the reference mouse DNA sequence in FASTA format. The reference 
file was indexed by bowtie-build and used by Bowtie 2 to perform the mapping of the HF-
SAMP6-over-LF-SAMP6 RNA-Seq reads to the reference mouse genome. Following 
alignment of the RNA-Seq reads, the data need to be translated into a quantitative measure of 
gene expression. This task can be achieved by TopHat, which counts the number of reads that 
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map a given gene. To perform this, it is necessary a reference file that contains all the 
annotated protein coding and non-coding genes in the mouse genome release 10. This 
information is contained on a GTF file that was downloaded from Ensemble’s website 
(ftp://ftp.ensembl.org/pub/release-71/gtf/homo sapiens/Homo sapiens.GRCh37.71.gtf.gz).  
 After running TopHat, the output file fed into Cuffquant to compute gene and 
transcript expression profiles and saves these profiles such that it can be analyzed in a timely 
manner by Cuffdiff which the last step is to determine differential gene expression (DGE). 
Cuffquant take the .bam mapping files made from each of the 6 biological replicates along 
with the merged.gtf file and generate .cxb (compressed binary file). Cuffquant reduces the 
computational load of quantifying gene and transcript expression of the HF-SAMP6-over-LF-
SAMP6 sample especially if there are more than a handful of libraries.  
 Given the samples and the respective conditions that constitute the diet induced 
SAMP6 mice dataset, it was decided to compare SAMP6 HFD-fed to LFD-fed mice samples. 
Cuffdiff is a program that uses the cufflinks transcript quantification engine used to test the 
observed log fold change in its expression against the null hypothesis of no change and find 
differentially regulated genes and transcripts at the transcriptional and post-transcriptional 
level that share a common transcription start site.  
The Cuffdiff module takes two or more fragment alignment BAM files from TopHat 
(such as accepted_hits.bam), as well as a reference GTF file containing transcript annotations 
as input. To do so, each one of the outputs from the previous step was concatenated with the 
table containing the information about the gene expression level in the control sample. From 
these concatenated tables, Cuffdiff estimates the dispersion of each gene and analyses 
whether there is differential expression between the defined conditions (e.g. comparison 
between SAMP6 HFD-fed compare to LFD-fed mice). The final throughput of this step is a 
table in which the entries correspond to the genes that are significantly differentially 
expressed among the two conditions being compared.   
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 Our analysis included a total of 23,285 differentially expressed genes including 
protein coding transcripts and non-coding transcripts, lncRNAs, and microRNA from the 
SAMP6 HFD-fed compare to LFD-fed mice. Of these 387 genes were significantly 
differentially expressed between High fat and Low-fat diet mice according to the cut-off 
criteria (P<0.05 and |log2FC| >1.5). Now Cuffdiff result output is very large and is not 
possible to visualize the data. So, we have used CummeRbund to simplify the analysis and 
visualize the output of a differential expression analysis by using cuffdiff. CummeRbund 
handles the transformation of Cuffdiff data into the R statistical computing environment, 
making RNA-Seq expression analysis with Cuffdiff more compatible with many other 
advanced statistical analyses and plotting packages. CummeRbund takes the output files from 
cuffdiff and creates an SQLite database which describes the relationships between genes, 
transcripts, transcription start sites, and CDS regions.  
This data can be represented in an MDS-plot, illustrates the pattern of similarities or 
distances among a set of objects (Figure-5.1). More specifically, each dot in the MDS-plot 
corresponds to a gene. In the x-axis in the plot represents the first euclidean dimension, and 
the y-axis the second euclidean dimension.  
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Euclidean distances can be placed in a several ways. These distances can be placed in 
multidimensions but the standard way of representing MDS is to just plot the Euclidean 
distances with x-axis being Dimension 1 and y-axis being Dimension 2. The dimensions are 
ordered based on how well samples are separated. Figure-3.2 is represented the MDS-plots 
for all the high fat and the low-fat diet induced to the SAMP6 mice. The closer the labels are 
together, the more similar the samples are. So, it is good to see that the high fat diet samples 
are clearly separated from the low-fat diet treated samples. In addition to this, genes classified 
as significantly differentially expressed with an FDR less than 0.1 in high fat and the low-fat 
diet induced to the SAMP6 mice are also clearly separated. By visually comparing the MDS-
plots of diet induced SAMP6 mice samples lead us to check another dimension reduction 
technique such as Principal Component Analysis. It minimizes the dimensions and preserves 
the covariance of data whereas MDS minimizes dimensions, preserves distance between data 
Figure 5.1. A multidimensional scaling (MDS) plot of the merged gene expression
data. MDS-plots for all the high fat and the low fat diet induced to the SAMP6 mice.
The figure shows a perfect separation between high fat SAMP6 and low fat SAMP6
mice. All color coded by biological replicates, with different symbols corresponding to
different replicates.
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points. Figure-5.2 is represented the PCA-plot that shows a perfect separation between high-
fat and low-fat diet biological replicates. In this method, the samples data points are projected 
onto the 2D plane in such a way so that data points are spread out in the two directions. This 
explain most well separation in the datapoints in the two-dimensional space. In the MDS plot, 
the x-axis is the direction that shows the maximum variation in the data point and is 
written PC1. The y-axis is orthogonal to the first direction which separates the data point 
second most in this direction and is written PC2. The percentage of total variance is 
demonstrated in the axis label which shows maximum variation.  
 
However, it is important to keep always in mind that this analysis was performed with any 
number of biological replicates. In fact, as stated before, it is important to note that the 
biological conclusions extracted from the described methodologies must be interpreted with 
care. In fact, differences in library construction and variability intrinsic to the biological 
samples can greatly influence the number of false positives. It is imperative to have 
Figure 5.2. Principal component analysis. The PCA analysis was
based on the gene expression patterns in high fat (HF) and low fat
(LF) SAMP6 mice with induction of different diet. Analysis showed
a perfect separation between two different diets. In the figure,
LF_SAMP6_1 overlapped with LF_SAMP6_2.
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biological replicates in the RNA-Seq dataset since these are essential in the measurement of 
the sample’s intrinsic variability. Therefore, the absence of replicates is reducing the power 
of DE inference among RNA-Seq samples. After performing this analysis, we have decided 
to perform an additional layer of analysis that enables to see the functions of those 
differentially expressed genes. 
5.3. Gene Ontology enrichment – GOStats 
Using the pre-set options defined in the tailor pipeline, GOStats identified the 
statistically significant ontology terms that differ between SAMP6 HFD-fed compare to 
LFD-fed mice. In the following subsections a summary of the obtained results is described 
and compared with what it was expected, having into account that urinary voiding 
dysfunction was more severe in SAMP6 and was associated with pronounced prostatic and 
urethral tissue fibrosis. The X-axis represent the –log10 (p-value) and the Y-axis represent the 
biological, cellular or the molecular processes.  
 5.3. A Biological Processes: 
SAMP6 HFD-fed compare to LFD-fed mice analysis provided significant ontologies that 
described operations or sets of molecular events pertinent to the functioning of fibrosis that 
are associated with diet induced high fat mice. In all, 13 biological processes were highly 
over-represented in our gene list, with p-values < 0.05 and fold-enrichment values of >2-fold 
(Table - 5.2).  
Table – 5.2 Summary of the BP ontology terms and respective p-value associated with the set 
of differentially expressed genes from SAMP6 HFD-fed compare to the LFD-fed analysis. 
GOBPID Odds Ratio Term -log10(P-value) 
GO:0009605 Inf response to external stimulus 3 
GO:0009611 45.863 response to wounding 3 
GO:0001907 1836.556 killing by symbiont of host cells 3 
GO:0032571 1836.556 response to vitamin K 3 
GO:0044004 1836.556 disruption by symbiont of host cell 3 
GO:0051919 1836.556 positive regulation of fibrinolysis 3 
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GO:0007598 1377.333 blood coagulation, extrinsic pathway 3 
GO:0065008 Inf regulation of biological quality 2.69897 
GO:0016485 51.987 protein processing  2.69897 
GO:0080134 32.604 regulation of response to stress 2.69897 
GO:0051604 48.202 protein maturation 2.69897 
GO:0017187 500.636 peptidyl-glutamic acid carboxylation 2.522879 
GO:0018214 500.636 protein carboxylation 2.522879 
GO:0051818 500.636 
disruption of cells of other organism 
involved in symbiotic interaction 
2.522879 
GO:0051883 500.636 
killing of cells in other organism involved 
in symbiotic interaction 
2.522879 
GO:0006508 28.997 Proteolysis 2.522879 
GO:0006828 458.889 manganese ion transport 2.522879 
GO:0010640 458.889 
regulation of platelet-derived growth factor 
receptor signaling pathway 
2.522879 
GO:0051917 458.889 regulation of fibrinolysis 2.522879 
GO:0006957 393.286 
complement activation, alternative 
pathway 
2.39794 
GO:0007597 305.815 blood coagulation, intrinsic pathway 2.30103 
GO:0031639 275.2 plasminogen activation 2.30103 
GO:0030194 239.261 positive regulation of blood coagulation 2.221849 
GO:0050927 239.261 positive regulation of positive chemotaxis 2.221849 
GO:1900048 239.261 positive regulation of hemostasis 2.221849 
GO:0050926 229.278 regulation of positive chemotaxis 2.221849 
GO:0050820 220.093 positive regulation of coagulation 2.221849 
GO:0007596 28.787 blood coagulation 2.221849 
GO:0042730 211.615 Fibrinolysis 2.154902 
GO:0007599 28.521 Hemostasis 2.154902 
GO:0050817 28.521 Coagulation 2.154902 
GO:0030449 196.476 regulation of complement activation 2.154902 
GO:0018200 189.69 peptidyl-glutamic acid modification 2.154902 
GO:0019835 189.69 Cytolysis 2.154902 
GO:0031640 189.69 killing of cells of other organism 2.154902 
GO:0044364 189.69 disruption of cells of other organism 2.154902 
GO:2000257 183.356 regulation of protein activation cascade 2.154902 
The differential biological processes analysis shows that “GO:0007598”, “GO:0017187” and 
“GO:0051818” are top most over-represented. The associated processes are blood 
coagulation, extrinsic pathway, peptidyl-glutamic acid carboxylation and disruption of cells 
of other organism involved in symbiotic interaction.  
SAMP6 HFD-fed compare to LFD-fed mice has led us to provide deregulation of 
wound healing response, coagulation is responsible for the tissue fibrosis. Over the last 
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decade, coagulation signaling coordinate inflammation and tissue repair through the 
generation of fibrin and activation of proteinase-activated receptors (PARs) (Kryczka and 
Boncela, 2017). Coagulation cascade promote hemostasis and limit blood loss in response to 
tissue injury which will help to promote tissue fibrosis. Therefore, targeting the PARs will be 
a potential approach to limit fibrosis.  
 From this evaluation it is possible to conclude that the main differences between 
SAMP6 HFD-fed compare to LFD-fed mice is high fat diet induced SAMP6 mice associated 
with blood coagulation, extrinsic pathway which is a key factor for the tissue fibrinolysis 
which is concomitant to tissue fibrosis in high fat diet mice.  
 5.3. B Cellular Components:  
Cellular components ontology associated with parts of a cell or its extracellular environment. 
Comparing SAMP6 HFD-fed to LFD-fed analysis, “GO:0005579” and “GO:0005615” were 
over-represented cellular components (Table - 5.3).  
Table - 5.3 Summary of the CC ontology terms and respective p-value associated with the set 
of differentially expressed genes from SAMP6 HFD-fed compare to the LFD-fed analysis. 
GOCCID Odds Ratio Cellular Components -log10(P-value) 
GO:0005615 37.326 extracellular space 2.69897 
GO:0005579 986.167 membrane attack complex 2.69897 
GO:0046930 369.604 pore complex 2.39794 
GO:0005886 Inf plasma membrane 2.221849 
The associated terms were membrane attack complex and extracellular space. The –log10 (P-
Value) is highly enriched for the term “membrane attack complex”. Remembering that BP 
“blood coagulation” is highly overrepresented for the SAMP6 HFD-fed compare to the LFD-
fed analysis. But in the case of cellular components, membrane attack complex is highly over 
represented. Evidence suggested that formation of membrane attack complex direct 
associated with accumulation of fibrosis and complement activation may be responsible for 
the profibrotic response that occurs in the tubulointerstitial compartment (Abe 2004). 
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Stimulation of proximal tubular epithelial cells with membrane attack complex increased the 
mRNA concentrations of collagen type IV and its intracellular chaperone such as Heat Shock 
Protein 47 (HSP47).  
 5.3.C Molecular Functions: 
The significant MF were described the elemental activities of a gene product at the molecular 
level. Only one GO term is associated with the molecular function in this analysis. The GO 
term “GO: 0004252” is associated with serine-type endopeptidase activity (Table - 5.4).  
Table - 5.4 Summary of the MF ontology terms and respective p-value associated with the set 
of differentially expressed genes from SAMP6 HFD-fed compare to the LFD-fed mice 
analysis. 
GOMFID Odds Ratio Molecular Functions -log10(P-value) 
GO:0070679 1038.000 inositol 1,4,5 trisphosphate binding 2.69897 
GO:0004175 76.749 endopeptidase activity 2.69897 
GO:0015279 830.300 store-operated calcium channel activity 2.69897 
GO:0070011 55.297 
peptidase activity, acting on L-amino 
acid peptides 
2.39794 
GO:0008233 53.387 peptidase activity 2.39794 
In has been reported, protease may target many substrates which activate cell migration and 
fibrosis which support statistically (Kryczka and Boncela, 2017). Furthermore, serine-type 
endopeptidase activity is also described to be related with the mesenchymal transition and 
fibrosis. On the other hand, this activity term evidences the regulation of cell junction 
decomposition and ECM degradation. This may help to liberate sequestered growth factors 
such as TGFβ or VEGF that increases leukocytes infiltration and prolong inflammation. 
Finally, these proteases target many substrates and thus inflicting changes in distinct 
biological processes which correlated with cell migration and fibrosis (Kryczka and Boncela, 
2017).  
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5.4. Pathway Analysis: 
Finally, the list of differentially expressed genes can be grouped into common pathways. This 
analysis identifies differentially active pathways and, ultimately, possibilities the connection 
of molecular information (transcriptome) with the SAMP6 HFD-fed compare to the LFD-fed 
mice analysis. Gene Ontology analysis reveals high fat diet SAMP6 mice involved in blood 
coagulation process which plays pivotal roles in orchestrating inflammatory response. In 
addition to this high fat diet SAMP6 mice engaged in membrane attack complex which is 
directly associated with accumulation of fibrosis. This insinuates us to check the significant 
pathway which may associate with fibrosis. 
 Tailor pipeline identified 39 significantly differentially expressed pathways. Pathway 
enrichment analysis evaluates the significantly differentially expressed genes that concatenate 
into cellular pathways. The Kyoto Encyclopedia of Genes and Genomes (KEGG) is a public 
repository that contains pathway information (Kanehisa 2012). This is performed by relating 
the pathway information into these databases with the gene expression patterns, resulting in 
the transformation of the list of individual genes into a set of pathways. Previously report 
suggested up-regulation of a pre-fibrotic pathway namely the “ECM-Receptor Interaction” 
has been associated with fibrosis (Ekstedt 2006).  
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The ECM plays a central role to maintain the normal function of different tissues. It has been 
widely comprehended, over-expression of extracellular matrix (ECM) proteins have been 
associated with fibrosis (Almanza, D., 2018). In our analysis it can be shown collagen is up-
regulated which presumably participates in the development of tissue fibrosis (Figure-5.3). 
Though diet induced SAMP6 mice did not show any fibrotic livers, may be this pathway 
insinuate the early stage of tumorigenesis. Apart from the extra cellular matrix pathway we 
have observed an unusual pathway known as the “peroxisome proliferator-activated receptor 
pathway” is highly over-expressed in our analysis (Figure-5.4).  
 Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription 
factors of nuclear hormone receptor super family composed of three members namely PPAR-
α, PPAR-δ, and PPAR-γ and play an essential role in metabolism by heterodimerization with 
Figure 5.3. KEGG pathway of mm10 illustration of ECM receptor pathway. ECM
receptor interaction showed differential expression of specific genes in this pathway.
Genes significantly up-regulated consequent to high fat diet treatment in red, up-regulated
consequent to low fat diet treatment in green, not differentially expressed in gray
(arbitrary scale indicates extent of differential expression).
44 
 
the retinoid X receptor (RXR) that bind to the specific regions on the DNA of the target 
genes. From the signaling pathway it can be visualized that PPAR-γ is targeted many genes 
such as ME1, ACBP, FABP1, LPL, ACO, CYP4A1, Thiolase B. Their main function is to 
promote lipogenesis, cholesterol metabolism, fatty acid transport, fatty acid oxidation. Due to 
down regulation of PPAR-γ in SAMP6 HFD-fed compare to the LFD-fed mice analysis, all 
the downstream target genes become down expressed and will not be able to transport fatty 
acid. Finally, oxidation of fatty acid and the metabolism of cholesterol become inhibited. 
Now chronic imbalances in lipid metabolism are often associated with obesity, Type-2 
diabetes (T2D) and chronic liver disease. The common cause of chronic liver disease is the 
nonalcoholic fatty liver disease (NAFLD) disease which is responsible to accumulate the 
white adipose tissue in the liver (Ekstedt 2006). In this analysis we can visualize that 
oxidation of fatty acids are down regulated, suggested us to speculate that blood levels of 
triglycerides and free fatty acids are chronically elevated and excess fatty acids are derived 
from the extracellular source such as diet. Finally, it is reported that in liver, chronically 
elevated fat deposits result in NAFLD, which can lead to steatohepatitis (NASH) and, 
eventually, to non-reversible hepatic cirrhosis (Ekstedt 2006).  
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 It has been reported that NAFLD can develop a worst prognosis like cirrhosis and 
hepatocellular carcinoma (Yu 2016). In hepatocellular carcinoma, several different 
biomarkers have documented recently, and our aim is to find any of these known biomarkers 
are presented in our diet induced mice samples. After performing differential gene expression 
analysis by cuffdiff, we have identified genes/transcripts that are significantly differentially 
expressed in hepatocellular carcinoma. It is worth mentioning that several growth factors 
such as EGF1, EGF2 are upregulated in our diet induced SAMP6 mice model system and we 
are suspecting these may provide a pre-malignant signature. Because, EGFR plays an 
important role in cell growth and concurrently lead to the development of transformation by 
increasing the transcriptional activity. However, this premalignant signature has been 
implicated in cancer considering this may play an important role for uncontrolled cell growth 
and proliferation which is a characteristic feature of cancer (Grandhi 2016). 
Figure 5.4. KEGG pathway of mm10 illustration of peroxisome proliferator-activated receptor
(PPAR) pathway. PPAR pathway showed differential expression of specific genes in this pathway.
Genes significantly up-regulated consequent to high fat diet treatment in red, up-regulated consequent to
low fat diet treatment in green, not differentially expressed in gray (arbitrary scale indicates extent of
differential expression).
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Part-II. Stromal Fibroblast Cell line results 
5.5. Dataset Description 
In this analysis N1 cells were used and these cells were derived from a stromal 
fibroblast cell line. These cells were expressed fibroblastic markers such as vimentin and 
calponin. These cells were demonstrated proliferation and secretion profiles which was 
somewhat similar with aging primary prostate fibroblasts (Rodríguez-Nieves 2016). 
Fibroblast cells were treated with human CXCL12 and human TGFβ and Trizol is used to 
extract RNA. Isolated RNA from N1 cells treated with CXCl12 or TGFβ were used to 
prepare libraries. All RNA samples are DNAse treated and used to create single indexed (6 
base pairs) RNA-Seq libraries by using TruSeq RNA preparation kit according to the 
manufacturer’s protocol. All sequencing has been done by using the Illumina HiSeqTM 2500 
instrument. HiSeqTM 2500 was used to sequence RNA-Seq libraries that have been loaded 
with software version 3. Then performed 51-cycle paired-end run of the single indexed RNA-
Seq libraries and demultiplexing has been done by using the raw bcl base call files upon 
completion. The experimental data is composed 3 biological replicates for each of the 2 
different conditions mentioned such as CXCL12-vs-Control, TGFβ- vs- Control, and 
CXCL12-vs-TGFβ.   
5.6. Differential Gene Expression 
The pipeline described above was used to process the experimental data characterized above. 
In the subsequent section results from each processing step, interpretation and ultimately, 
conclusion has been made to decipher which are the up- and down- regulated pathways in 
CXCL12-vs-TGFβ induced fibroblast to myofibroblast phenoconversion. The .Bcl basecall 
files generated by Illumina HiSeq2500 were converted to FASTQ format using 
Tailor_Pipeline. This conversion was done with the help of bcl2fastq tool. To generate a 
single FASTQ file for each biological replicate, we have used the default parameter that split 
the files after 4 million reads to the reference human genome. This alignment file will be used 
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in the further downstream analysis of the stromal fibroblast data. In this analysis we have 
mainly focused on the Cuffdiff that enables to perform the differential gene expression 
analysis for the quantification of the transcripts for the samples. In computational biology it’s 
important to know the function the genes/transcripts which is differentially expressed in the 
sample and gene ontology analysis is the prime important for this field and we have used 
GOStats R package to analyze the result considering that we have kept p-value of ≤0.05. In 
cell line data analysis, we have considered the pathview package that associated with the 
enrichment analysis. This enrichment analysis used to elucidate and visualized the top up-
regulated cellular pathways, or down-regulated in CXCL12, or TGFβ treated cells by 
considering the cutoff q value ≤0.05. Transcriptomics analysis using human N1 cells which 
were derived from a stromal fibroblast demonstrated secretion and proliferation profile which 
was consistent with aging primary prostate fibroblasts (Patalano 2018). Moreover, RNA-Seq 
analysis of stromal fibroblast data revealed total of 10,633 transcripts were induced by 
CXCL12 or TGFβ compared to controls.  
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These studies utilized human N1 cells which were derived from a stromal nodule of benign 
prostatic hyperplasia, exhibit a fibroblastic morphology, and demonstrate secretion and 
proliferation profiles consistent with aging primary prostate fibroblasts. Analysis of RNA-
Seq data revealed that a total of 10,633 transcripts were induced by CXCL12 and TGFβ 
compared to vehicle controls. Of these, 9378 (82.5%) transcripts were significantly 
differentially expressed by CXCL12 and TGFβ, 734 (6.5%) were differently expressed 
consequent to TGFβ treatment only, 1255 (11%) by CXCL12 treatment only as it can be seen 
in figure 5.5.  
 Recent transcriptomics analysis reveals an astounding number of non-coding RNAs 
(ncRNAs) present in human genome. These ncRNAs have lack the capacity to code for a 
protein. Therefore, to date, these ncRNAs are as a “dark matter” and “junks” of human 
genome. Yet, over the past decade, several studies have shown these ncRNAs have numeral 
biological functions. However, it is still in debate, whether, ncRNAs transcription reflects 
accurate biology or offshoot of a leaky transcriptional system. Now, it is a broad question 
how we can able to interpret the biological meaning of transcription that distinguishes a gene 
that is simply transcribed.  
 Depending on the type of ncRNAs, transcription can occur by incorporating three 
RNA polymerases namely RNA Pol I, RNA Pol II and RNA Pol III. ncRNAs can be 
classified into two categories such as small ncRNAs and long ncRNAs depending upon the 
size. Recently, long noncoding RNAs (lncRNAs) are emerging aspect of modern biology, 
especially their role in human diseases have come into our attention. Many lncRNAs with 
tumor-suppressor or oncogenic functions in cancer have been discovered. However, genome-
wide transcriptomics study mediated by high-throughput sequencing technique has 
revolutionized the genomics study and the pipeline identified lncRNAs that are significantly 
differentially expressed in stromal fibroblast cell line and have their role in tissue fibrosis.  
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 We used RNA-Seq dataset that was acquired from N1 cells treated with CXCL12 or 
TGFβ. The experimental data is composed 3 biological replicates for each of the 2 different 
conditions. The datasets were sequenced by using paired-end sequencing on an illumina 
Hiseq-2500.  
5.7. Prediction of fibrosis associated lncRNAs: 
 In this study, transcripts were reconstructed by using the genome guided methods. 
Current transcriptomics study falls into two categories based on the availability of genome: 
genome-guided and genome independent de-novo assembly (Garber et al., 2011). Also, we 
have determined the coding potential of lincRNAs was proposed in this study. First, TopHat 
was used to map the RNA-Seq reads in each sample to the human GRCh38 reference genome 
and 85.9% of the total RNA-Seq reads in each sample have been successfully mapped to the 
reference genome. Then, Cufflinks was subsequently used to assemble these aligned reads 
into transcripts based on the known gene annotation (Trapnell 2004), and the assembled 
transcripts were annotated and grouped into different categories using the Cuffcompare 
program from the Cufflinks package.  
 The fundamental aim of differential expression analysis is to identify genes that 
change in abundance between different experimental conditions. In this study, we used 
Cuffdiff (a module in Cufflinks package), to detect significantly differentially expressed 
lncRNAs between the CXCL12-vs-TGFβ induced stromal fibroblast tissues (Trapnell 2012), 
where the false discovery rate (FDR) was set to be 0.05.  
 High-throughput sequencing followed by bioinformatics analysis is a main stream of 
detecting the lncRNA. They have recently gained an attention due to their widespread 
involvement in disease. Based on the differentially expressed lncRNAs, we have performed 
cluster analysis to see the variation of expression between CXCL12 and TGFβ compared to 
control as it can be seen in figure 5.6.  
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From the analysis the expression levels of the significantly differentially expressed lncRNAs 
have altered. Based on that, we have identified lncRNAs namely MALAT1, NEAT1, TUG1, 
PTENP1, Kcnq1ot1, DNM3OS, Scarb2, SRSF9, SNHG16, FADS1, WRAP53, HEIH, HEIH, 
HOTAIRM1, SNHG11, DMPK, PVT1, MAP3K14, SNHG3, SRA1, GAS5, TERC that were 
upregulated in our analysis. Of these differentially expressed lncRNAs, we have observed 7 
lncRNAs namely MALAT1, NEAT1, TUG1, PTENP1, Kcnq1ot1, DNM3OS and Scarb2 are 
upregulated in both CXCL12 and TGFβ induced N1 cell line. MALAT1 involved promoting 
tumor growth and metastasis and regulate alternative splicing and cell cycle regulation that 
may associated with Prostate cancer (Cheetham 2013). MALAT1 increased HCC cell 
migration; tumor metastasis and recurrence through Wnt/TCF/β-catenin and Hippo/yes-
associated protein (YAP) signaling pathways (Nordin et al 2014; Wang et al. 2014). NEAT1 
51 
 
has proven to be a transcriptional regulator for numerous genes; few of them are involved in 
liver and prostate cancer progression and promoted cell proliferation and invasion 
(Chakravarty 2014). TUG1 has also been suggested to be significantly associated with 
hepatocellular carcinoma and promoted cell growth and apoptosis (Mehra and Chauhan 
2017). Finally, PTENP1 is a highly homologous processed pseudogene of the tumor 
suppressor gene PTEN that itself exerts a tumor suppressive function by acting as a decoy for 
PTEN targeting miRNAs (Poliseno 2010). Chen et al, reported the main function of PTENP1 
is to repress tumorigenic properties of HCC. The role of lncRNA potassium voltage‑gated 
channel subfamily Q member 1 opposite strand/antisense transcript 1 (KCNQ1OT1) is 
remain elusive in the context of myofibroblast phenoconversion. It is transcribed from intron 
10 of the maternally expressed Kncq1 (KvLQT1) gene from a CpG island that is the 
imprinting control region (IC2) (Smilinich 1999). It has been reported that lncKCNQ1OT1 
has been associated with diverse array of functions. Of these, one of the most important 
function is the involvement of cell proliferation. Because KCNQ1OT1 promotes cell 
proliferation through the upregulation of SMAD4 which is upregulated in both CXCL12 and 
TGFβ treated cell line. Previously, it was reported that TGFβ promotes the myofibroblast 
phenoconversion through SMAD dependent pathway. Furthermore, the results indicated that 
an increase level of KCNQ1OT1 may correspondingly regulate SMAD4 expression levels. 
So, we may suspect the lncRNA KCNQ1OT1 may promote fibroblast to myofibroblast 
phenoconversion through SMAD dependent pathway. DNM3OS, a gene that is transcribed 
into a non-coding RNA (ncRNA), contains three micro RNAs (miRNAs), miR-199a, miR-
199a*, and miR-214, whose functions remain unknown. It has been reported the long non-
coding RNA DNM3OS as a critical downstream effector of TGF-β-induced myofibroblast 
activation via SMAD dependent pathway. However, in the context of stromal fibroblast cell 
line, it remains unknown their function and the mechanism through which they promote 
myofibroblast phenoconversion. Hence, it may provide a novel paradigm for the treatment of 
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fibrosis. Finally, the function of lncRNA Scarb2 in cell proliferation is still elusive and need 
to be further investigated. The differentially expressed lncRNAs have been documented in 
the table 5.5.   
Table 5.5: 
Gene Name 
Location 
CXCL12 treated-vs control 
TGFβ treated-vs control 
Fold change Q-Value Fold change Q-Value 
MALAT1 11q13.1 1.995986551 0.000074448 2.229654234 0.000081672 
NEAT1 11q13.1 1.568616847 0.000074448 1.686939226 0.000081672 
TUG1 22q12.2 2.635305103 0.000074448 2.894210791 0.000081672 
PTENP1 9p13.3 1.390510848 0.0040057 1.922231374 0.000081672 
Kcnq1ot1 11p15.5 2.31493229 0.0000820 2.2448359 0.0000885787 
DNM3OS 1q24.3 1.92294833 0.0000820508 2.458008662 0.0000885787 
Scarb2 4q21.1 1.6579724 0.0000820 1.888684862 0.0000885787 
SRSF9 12q24.31 0.571988878 0.0000820508 0.596421843 0.0000885787 
SNHG16 17q25.1 0.780392598 0.0000820508 0.635598665 0.0000885787 
FADS1 11q12.2 0.828545597 0.0452502 0.637077592 0.00017404 
WRAP53 17p13.1 0.59680023 0.0000820508 0.464709164 0.0000885787 
HEIH 5q35.3 0.540972064 0.0000820508 0.629099011 0.0000885787 
HOTAIRM1 7p15.2 0.606565774 0.0000820508 0.67005666 0.000258076 
SNHG11 20q11.23 0.70463791 0.000315805 0.738212463 0.00183138 
DMPK 19q13.32 0.623637679 0.0000820508 0.78306013 0.0000885787 
PVT1 8q24.21 0.669973065 0.0000820508 0.532798897 0.0000885787 
MAP3K14 17q21.31 0.671974783214 0.00120927 1.076055134 0.0032499 
SNHG3 1p35.3 0.653230926 0.00120927 0.531131868 0.0327341 
SRA1 5q31.3 0.604459674 0.0000820508 0.610607832 0.0000885787 
53 
 
GAS5 1q25.1 0.73045991 0.0000820508 0.691657636 0.0000885787 
TERC 3q26.2 0.412029631 0.0000820508 0.563245583 0.0000885787 
In CXCL12 treated cell, COL1A1 and smooth muscle α-actin (αSMA) is upregulated but not 
TGFβ treatment. It’s an open area of research whether silencing of MALAT1 reduces the 
mRNA levels of smooth muscle α-actin (α-SMA) and collagen type I, α1. However, to the 
best of our knowledge, there have been no published studies to demonstrate the specificity of 
these genes in fibroblast tissue. Thus, the results of this study can open a new theoretic 
insight into the identification of fibrosis specific genes.  
5.8. Prediction of fibrosis associated miRNAs: 
Identification of lncRNA by using the Tailor pipeline, our next question is whether any other 
short noncoding RNA that may differentially expressed to promote myofibroblast 
phenoconversion. Specially, microRNAs (miRNAs), play a crucial role in tumorigenesis and 
attenuates TGF-β signaling to stimulate angiogenesis and tumor growth (Bartel 2009; Suzuki 
and Miyazono 2011). They also play a significant role in tumor suppression in cancers 
(Hwang and Mendell 2006). Thus, we may hypothesize that miRNAs might be the important 
regulators to proliferate cancer cell and to promote myofibroblast phenoconversion. 
By RNA-Seq, we found 9 miRNAs namely miR100HG, miR143HG, miR17HG, 
miR210HG, miR22HG, miR4435-2HG, miR663A, miR663AHG and miR-let7BHG that had 
significantly differentially expressed based on q-value < 0.05 and considering they may have 
a role in promoting myofibroblast phenoconversion. Our bioinformatics analysis revealed 
differentially expressed miRNAs, we have performed cluster analysis to see the variation of 
expression between CXCL12 and TGFβ compared to control as it can be seen in figure 5.6. 
From the hierarchical analysis it can be revealed miRNAs expression have been altered. Of 
note, the two most upregulated miRNAs are miR100HG and miR22HG (Fig. 5.7) that may 
interest in this analysis and assuming their possible role is to promote myofibroblast 
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phenoconversion. Though it’s suspected but not validated yet their positive role in 
myofibroblast phenoconversion. The detailed list of miRNAs has been documented in the 
table 5.6. MIR100HG is a polycistronic miRNA host gene, which encodes miR-100, let-7a-2, 
and miR-125b-1 within its third intron, involved in cell proliferation and differentiation 
(Emmrich et al., 2014). Previous reports showed that miRNAs played an essential role in 
fibrosis, while the mechanism was not clear and needed  
 
more elucidation. The detailed information of upregulated miRNAs is documented in table 
5.6. Furthermore, over-expression of miR-100HG and miR-22HG in this stromal fibroblast 
cell line upon inducing the TGFβ highlighting a miRNA-mediated regulatory network 
potentially important for cellular proliferation.  
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Table 5.6: 
Gene Name 
Control 
(FPKM 
value) 
CXCL12 
treated –vs 
control 
(FPKM 
value) 
TGFβ 
treated -vs 
control 
(FPKM 
value) 
Fold Change Q-Value 
MIR100HG 5.97311 14.3705 17.3948 2.66289118 0.00007806 
MIR143HG 1.74695 0.776572 1.13852 0.549678074 0.01771129 
MIR17HG 3.634215 2.72922 2.48242 0.716698003 0.00099742 
MIR210HG 5.14924 2.57128 4.27341 0.667055105 0.00813042 
MIR22HG 9.454085 11.4505 14.5692 1.378657307 0.00306516 
MIR4435-2HG 130.665 96.4805 86.2446 0.698804625 0.00007806 
MIR663A 35614.05 11488.3 16110.3 0.388444969 0.00007806 
MIR663AHG 88.0577 33.4411 55.4406 0.506454721 0.00007806 
MIRLET7BHG 3.408655 2.1428 2.26701 0.647233958 0.00007806 
However, Recent data suggested miR22HG upregulated and located in 17p13.3, a 
chromosomal region that is frequently deleted, hypermethylated in hepatocellular carcinoma 
[Zhang et al., 2018].  Previously, it was reported that miR22HG expressed significantly lower 
in HCC and an associated with the prognosis of patients with HCC. In the contrary, in our 
work we have noticed a significant increase in the expression of miR22HG and presumably it 
may promote myofibroblast phenoconversion. 
5.8. Revisit of aminoacyl tRNA synthetase 
Genes of ARS being housekeeping, for long their connection to diseases remained 
unsuspected. Their expressions vary dynamically from cell line to cell line and under stress 
conditions. Besides their major canonical role in translation, they are involved in pathways of 
cell signaling, cell survival, metabolisms of amino acids, stress response programs, 
regulations of enzyme synthesis and apoptosis. Many consider them to be hotspots of the 
regulation system (Ibba, M. & Söll, D. 2001).  
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In human there are 37 ARS genes, distinguished into two distinct sets based on their 
locations, either in cytoplasm (designated with single letter amino acid code followed by RS) 
or in mitochondria (has a ‘2’ suffix). There are 17 cytoplasmic ARS (including the 
bifunctional glutamyl-prolyl-tRNA synthetase, EPRS, in charge for aminoacylation of 
tRNAGlu and tRNAPro), 18 mitochondrial, and 2 dual-localized, GARS and KARS, present 
in cytoplasm as well as in mitochondria (Yao, P. & Fox, P. L. 2013). 
Mammalian ARS interacts with multifunctional proteins (AIMPs) by catalyzing the ligation 
of amino acids to their cognate tRNAs. Along with catalytic activity domains, ARS has other 
motifs to interact with diverse regulatory factors. These structural convolutions are linked to 
functional flexibility, notably to oncogenic pathways of apoptosis, angiogenesis, cell growth, 
cell proliferation, signal transduction and many more (Park, S. G. et al.,2008). The deviations 
of ARS/ARS2 gene expressions presumably meet the differential protein needs of cancer 
cells, driving the malignancy. 
To observe the common transcription profile of the ARS/ARS2 genes, we performed a large-
scale RNA-seq analysis on all the considered datasets. RNA-Seq analysis of stromal 
fibroblast cell line, using 37 ARS/ARS2 gene expression signatures clearly pointed to the 
differential expression of ARS/ARS2 genes. Following different quality control and 
normalization procedures, differentially expressed genes (DEGs) were identified initially 
using a fold change cutoff of >2. The differential expressions of ARS/ARS2 in leukemia 
were visualized from the clusterogram, Fig. 5.8.  
Observation of large-scale alteration of ARS/ARS2 gene-expressions indicated that enhanced 
statistical analysis needed to be applied to identify more robust and reliable signatures. We 
integrated different statistical approaches to achieve superior result. P values of genes were 
calculated across samples to identify gene expression signatures that differentiated cancer 
tissues from normal tissues. Further, we computed FDR (False Discover Rate), to sharpen the 
significance of our result. Our RNA-Seq analysis, based on q-value (FDR test), showed that 
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IARS, IARS2, EPRS, LARS, NARS, TARS, WARS2, in stromal fibroblast cell line, were 
upregulated. To verify these anomalous expressions, we have seen that two AARS/AARS2 
namely NARS and WARS2 are upregulated in both the CXCL12 and TGFβ induced 
fibroblast cell line. 
As we observed varied rates of differentiation of ARS/ARS2 genes, it was assumed they took 
part in biological processes and molecular functions other than just in translation. Hence, we 
performed gene ontology (GO) analysis to determine the distribution of ARS/ARS2 genes in 
cell, the biological processes they took part in and the molecular functions they performed. 
From GO database we figured the precise scattering of ARS/ARS2 in and around a cell. 
Interestingly, they were not only restricted to cytosol and mitochondria but also dispersed in 
their surroundings. Remarkably, NARS, have the potential to promote tumor metastasis and 
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growth and WARS2 was involved in angiogenesis followed by migration and proliferation. 
Though what that implies functionally, still needs to be interpreted.  
5.9. Gene Ontology Analysis 
After performing the differential gene expression analysis, our next aim is to perform the 
gene ontology analysis to see any significantly upregulated ontology that was associated with 
the fibroblast to myofibroblast phenoconversion. Based on that in our developed tool, we 
used some condition in the gene ontology step to get the over represented GO-terms. In 
overrepresented GO terms, if the condition becomes TRUE, the hypergeometric test 
performed by using the conditional algorithm to estimate for each biological term whether 
they are statistically overrepresented at the specified p-value cutoff where it finds all child 
terms are significant. Calculation of log odds ratio (LR) revealed GO biological process 
(table 5.7) was profoundly weighted towards DNA synthesis in the TGFβ-mediated treatment 
whereas this was less evident in the CXCL12-mediated signature, where protein synthesis, 
protein metabolism, protein modification and ER to Golgi vesicle-mediated transport are 
more prominent.  
Table – 5.7 Summary of the BP ontology terms and respective p-value associated with the set 
of differentially expressed genes from CXCL12-over-control analysis. 
GOBPID Odds Ratio Term -log10(p-value) 
GO:0000183 24.82936394 chromatin silencing at rDNA 7.274905479 
GO:1990542 19.06785988 mitochondrial transmembrane transport 5.411168274 
GO:0007080 18.45824575 mitotic metaphase plate congression 5.217527376 
GO:0051204 16.14479465 
protein insertion into mitochondrial 
membrane 
4.480172006 
GO:0032508 15.8948578 DNA duplex unwinding 8.517126416 
GO:1903747 14.45812097 
regulation of establishment of protein 
localization to mitochondrion 
3.943095149 
GO:1900740 14.41086604 
positive regulation of protein insertion 
into mitochondrial membrane involved 
in apoptotic signaling pathway 
3.931814138 
GO:1901522 14.41086604 
positive regulation of transcription from 
RNA polymerase II promoter involved 
in cellular response to chemical stimulus 
3.931814138 
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GO:0051436 13.31509217 
negative regulation of ubiquitin-protein 
ligase activity involved in mitotic cell 
cycle 
6.896196279 
GO:0008625 13.29756425 
extrinsic apoptotic signaling pathway via 
death domain receptors 
3.580044252 
GO:0060444 13.25546539 
branching involved in mammary gland 
duct morphogenesis 
3.568636236 
GO:0010972 12.67793051 
negative regulation of G2/M transition 
of mitotic cell cycle 
3.388276692 
GO:0006418 12.41262554 
tRNA aminoacylation for protein 
translation 
6.341988603 
GO:0006302 11.90967462 double-strand break repair 6.022733788 
GO:0006120 11.83303051 
mitochondrial electron transport, NADH 
to ubiquinone 
5.982966661 
GO:0006595 11.52319145 polyamine metabolic process 3.029653124 
GO:0007004 11.52319145 telomere maintenance via telomerase 3.029653124 
GO:0031571 10.41741799 mitotic G1 DNA damage checkpoint 9.838631998 
GO:0019068 10.38302752 virion assembly 2.677987561 
GO:0043153 10.36889313 
entrainment of circadian clock by 
photoperiod 
2.674484337 
GO:0006415 10.02806271 translational termination 11.56703071 
GO:0033044 9.897565234 regulation of chromosome organization 2.524910197 
GO:0000097 9.791909169 sulfur amino acid biosynthetic process 2.498393078 
GO:0006895 9.791909169 Golgi to endosome transport 2.498393078 
GO:0006995 9.791909169 cellular response to nitrogen starvation 2.498393078 
GO:0032981 9.791909169 
mitochondrial respiratory chain complex 
I assembly 
2.498393078 
GO:0043984 9.791909169 histone H4-K16 acetylation 2.498393078 
GO:0072401 9.689339469 
signal transduction involved in DNA 
integrity checkpoint 
8.966576245 
GO:0006399 9.492567568 tRNA metabolic process 6.649751982 
GO:0072413 9.39830346 
signal transduction involved in mitotic 
cell cycle checkpoint 
8.617982957 
GO:1902402 9.39830346 
signal transduction involved in mitotic 
DNA damage checkpoint 
8.617982957 
GO:2001020 9.289625916 
regulation of response to DNA damage 
stimulus 
4.431798276 
GO:0006361 9.227594114 
transcription initiation from RNA 
polymerase I promoter 
4.401209493 
GO:0009226 9.215035299 nucleotide-sugar biosynthetic process 2.32339783 
GO:0046755 9.215035299 viral budding 2.32339783 
GO:0050687 9.215035299 
negative regulation of defense response 
to virus 
2.32339783 
GO:1902590 9.215035299 multi-organism organelle organization 2.32339783 
GO:1902400 9.107379013 
intracellular signal transduction involved 
in G1 DNA damage checkpoint 
8.272458743 
GO:0006900 8.959219858 membrane budding 4.238072162 
GO:0043038 8.660193246 amino acid activation 5.91721463 
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GO:1900101 8.647345302 
regulation of endoplasmic reticulum 
unfolded protein response 
2.151995729 
GO:0007096 8.638271487 regulation of exit from mitosis 2.149721447 
GO:0008535 8.638271487 respiratory chain complex IV assembly 2.149721447 
GO:0010664 8.638271487 
negative regulation of striated muscle 
cell apoptotic process 
2.149721447 
GO:0042772 8.638271487 
DNA damage response, signal 
transduction resulting in transcription 
2.149721447 
GO:0048194 8.638271487 Golgi vesicle budding 2.149721447 
GO:0051571 8.638271487 
positive regulation of histone H3-K4 
methylation 
2.149721447 
GO:0051788 8.638271487 response to misfolded protein 2.149721447 
GO:0060055 8.638271487 angiogenesis involved in wound healing 2.149721447 
GO:0006614 8.369598373 
SRP-dependent cotranslational protein 
targeting to membrane 
12.55284197 
GO:0006363 8.360110803 
termination of RNA polymerase I 
transcription 
3.886056648 
GO:0000184 8.128249567 
nuclear-transcribed mRNA catabolic 
process, nonsense-mediated decay 
13.69250396 
GO:0002042 8.071060172 
cell migration involved in sprouting 
angiogenesis 
3.714442691 
GO:0072599 7.981565268 
establishment of protein localization to 
endoplasmic reticulum 
13.35457773 
GO:0006413 7.963422108 translational initiation 11.69680394 
GO:0000723 7.918843642 telomere maintenance 5.258060922 
GO:0007569 7.807743979 cell aging 3.557520231 
GO:0034644 7.799597855 cellular response to UV 6.73754891 
GO:0048199 7.78206475 
vesicle targeting, to, from or within 
Golgi 
3.54515514 
GO:2000785 7.78206475 regulation of autophagosome assembly 3.54515514 
GO:0051437 7.750186943 
positive regulation of ubiquitin-protein 
ligase activity involved in regulation of 
mitotic cell cycle transition 
8.230622674 
GO:0006414 7.678671896 translational elongation 11.13489603 
GO:0019083 7.586166812 viral transcription 12.42945706 
GO:0070124 7.525527831 mitochondrial translational initiation 9.381951903 
GO:0070125 7.525527831 mitochondrial translational elongation 9.381951903 
GO:0050434 7.509285851 positive regulation of viral transcription 6.402304814 
GO:0006298 7.493124523 mismatch repair 3.375717904 
GO:0033014 7.493124523 tetrapyrrole biosynthetic process 3.375717904 
GO:0072583 7.493124523 clathrin-mediated endocytosis 3.375717904 
GO:1901028 7.308158062 
regulation of mitochondrial outer 
membrane permeabilization involved in 
apoptotic signaling pathway 
4.732828272 
GO:2001022 7.217753519 
positive regulation of response to DNA 
damage stimulus 
3.214670165 
GO:0000722 7.204239473 telomere maintenance via recombination 3.208309351 
GO:0046685 7.204239473 response to arsenic-containing substance 3.208309351 
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GO:0061615 7.204239473 
glycolytic process through fructose-6-
phosphate 
3.208309351 
GO:0061621 7.204239473 canonical glycolysis 3.208309351 
GO:1904292 7.204239473 regulation of ERAD pathway 3.208309351 
GO:0051188 6.943963027 cofactor biosynthetic process 3.055517328 
On the other hand, cellular component exhibited respiratory chain complexes, protein 
synthesis and degradation, and cell division were predominant in the TGFβ-mediated 
signature, whereas cellular signaling and Cul4-RING E3 ubiquitin ligase complex, clathrin 
vesicle coat, ECM component binding were prevalent in the CXCL12-mediated signature 
(table 5.8).  
Table - 5.8 Summaries of the CC ontology terms and respective p-value associated with the 
set of differentially expressed genes from CXCL12-over-control analysis. 
GOCCID Odds Ratio Term -log10(p-value) 
GO:0080008 14.94099 Cul4-RING E3 ubiquitin ligase complex 4.031517 
GO:0055029 13.77231 
nuclear DNA-directed RNA polymerase 
complex 
3.664996 
GO:0030125 13.69341 clathrin vesicle coat 3.645314 
GO:0005680 13.06978 anaphase-promoting complex 3.453179 
GO:0000502 12.81038 proteasome complex 6.473661 
GO:0030904 12.44627 retromer complex 3.26184 
GO:0005838 12.44627 proteasome regulatory particle 3.26184 
GO:0022625 11.23328 cytosolic large ribosomal subunit 8.095284 
GO:0015934 10.01159 large ribosomal subunit 4.785156 
GO:0034719 9.953378 SMN-Sm protein complex 2.506006 
GO:0005685 9.953378 U1 snRNP 2.506006 
GO:0070469 9.368798 respiratory chain 2.329249 
GO:0032040 9.341876 small-subunit processome 4.393619 
GO:0005762 9.341876 mitochondrial large ribosomal subunit 4.393619 
GO:0034045 9.330439 pre-autophagosomal structure membrane 2.319935 
GO:0030117 8.749517 membrane coat 5.88941 
GO:0030014 8.707614 CCR4-NOT complex 2.135281 
GO:0005849 8.707614 mRNA cleavage factor complex 2.135281 
GO:0042645 8.101777 mitochondrial nucleoid 5.329754 
GO:0030140 8.09333 trans-Golgi network transport vesicle 3.664145 
GO:0022627 7.684893 cytosolic small ribosomal subunit 4.970616 
GO:0005876 7.483634 spindle microtubule 6.261219 
GO:0005689 7.469399 U12-type spliceosomal complex 3.305304 
GO:0030686 6.845697 90S preribosome 2.951187 
GO:0000313 6.659933 organellar ribosome 7.767004 
GO:0000784 6.45774 nuclear chromosome, telomeric region 7.431798 
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GO:0005801 5.919117 cis-Golgi network 4.524329 
GO:1902555 5.910571 endoribonuclease complex 2.430589 
GO:0030137 5.910571 COPI-coated vesicle 2.430589 
GO:1990391 5.602764 DNA repair complex 3.234427 
GO:0036452 5.598976 ESCRT complex 2.260372 
GO:0005839 5.598976 proteasome core complex 2.260372 
GO:0000159 5.598976 protein phosphatase type 2A complex 2.260372 
GO:0016604 5.066767 nuclear body 3.602025 
GO:0030529 5.02695 ribonucleoprotein complex 16.29158 
GO:0098803 4.99055 respiratory chain complex 5.847712 
GO:0032154 4.9847 cleavage furrow 4.308035 
GO:0071339 4.978867 MLL1 complex 2.73702 
GO:0098687 4.949023 chromosomal region 9.453457 
GO:0016592 4.825659 mediator complex 3.366154 
GO:0044452 4.811433 nucleolar part 5.527244 
GO:0015935 4.78507 small ribosomal subunit 2.583606 
GO:0043601 4.770978 nuclear replisome 2.574413 
GO:0031519 4.734597 PcG protein complex 3.985908 
GO:1990234 4.649523 transferase complex 10.45469 
GO:0005763 4.563127 mitochondrial small ribosomal subunit 2.413596 
GO:0030880 4.549874 RNA polymerase complex 10.1707 
GO:0010494 4.5135 cytoplasmic stress granule 3.046508 
GO:0070603 4.507754 SWI/SNF superfamily-type complex 6.262013 
GO:0005840 4.37867 Ribosome 11.86646 
GO:0030660 4.36177 Golgi-associated vesicle membrane 4.127844 
GO:0097546 4.355314 ciliary base 2.254707 
GO:0032993 4.309986 protein-DNA complex 5.228413 
GO:0035097 4.29852 histone methyltransferase complex 5.79588 
GO:0005925 4.216674 focal adhesion 28.15677 
GO:0005657 4.209384 replication fork 5.037631 
GO:0030055 4.143092 cell-substrate junction 28.29073 
GO:0032153 4.095622 cell division site 4.277366 
GO:0005654 4.072825 Nucleoplasm 183.6421 
GO:0000118 3.974436 histone deacetylase complex 4.583359 
GO:0005730 3.841616 Nucleolus 49.5867 
GO:0000151 3.797252 ubiquitin ligase complex 15.45469 
GO:0016591 3.793665 
DNA-directed RNA polymerase II, 
holoenzyme 
6.9914 
GO:0016607 3.744944 nuclear speck 12.49349 
GO:0012507 3.736606 ER to Golgi transport vesicle membrane 3.216913 
GO:0016363 3.703721 nuclear matrix 6.69897 
GO:0005901 3.687077 Caveola 5.35164 
GO:0070013 3.674888 intracellular organelle lumen 207.567 
GO:0005643 3.617216 nuclear pore 4.754487 
GO:0031974 3.598013 membrane-enclosed lumen 222.266 
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GO:0031463 3.577708 Cul3-RING ubiquitin ligase complex 2.127909 
GO:0005819 3.49422 Spindle 6.39794 
GO:0097525 3.490056 spliceosomal snRNP complex 2.461535 
GO:0044424 3.486763 intracellular part 2.911095 
GO:0016605 3.479006 PML body 5.982967 
GO:0030496 3.409893 Midbody 7.954677 
GO:0000922 3.390406 spindle pole 7.510042 
GO:0072686 3.348538 mitotic spindle 3.418038 
GO:0005813 3.274238 Centrosome 20.87615 
GO:0098798 3.26026 mitochondrial protein complex 2.195246 
GO:0000228 3.186168 nuclear chromosome 25.06198 
GO:0005778 3.184547 peroxisomal membrane 3.456195 
GO:0005912 3.175634 adherens junction 24.30892 
GO:1902554 3.173936 serine/threonine protein kinase complex 4.08302 
GO:0005741 3.130656 mitochondrial outer membrane 8.247184 
GO:0000788 3.112128 nuclear nucleosome 2.360233 
GO:0008305 3.111162 integrin complex 2.032217 
GO:0005759 3.088013 mitochondrial matrix 16.54363 
GO:0000785 3.046311 Chromatin 4.928118 
GO:0000777 3.043233 condensed chromosome kinetochore 5.228413 
GO:0032592 3.035933 
integral component of mitochondrial 
membrane 
2.867686 
GO:0031902 2.948891 late endosome membrane 5.44855 
GO:0005694 2.932461 Chromosome 12.46344 
GO:0008180 2.904121 COP9 signalosome 2.089693 
GO:0005782 2.904121 peroxisomal matrix 2.089693 
GO:0005740 2.899519 mitochondrial envelope 30.49214 
GO:0000786 2.862159 Nucleosome 3.610763 
GO:0031201 2.8371 SNARE complex 2.789035 
GO:0005776 2.829458 Autophagosome 3.780958 
GO:0030027 2.818115 Lamellipodium 7.818156 
GO:0005905 2.804605 coated pit 3.470975 
GO:0005881 2.803116 cytoplasmic microtubule 2.97492 
GO:0031965 2.80047 nuclear membrane 10.00305 
GO:0005623 2.777139 Cell 97.72584 
GO:0019867 2.772263 outer membrane 8.223299 
GO:1903293 2.767649 phosphatase complex 2.660285 
GO:0005637 2.767649 nuclear inner membrane 2.660285 
GO:0005765 2.738271 lysosomal membrane 11.24642 
GO:0000792 2.733042 Heterochromatin 3.527382 
GO:0045121 2.70816 membrane raft 11.17783 
GO:0044438 2.660447 microbody part 3.768717 
GO:0001726 2.625921 Ruffle 3.664777 
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Molecular function analysis revealed that CXCL12 and TGFβ related genes encoded proteins 
involved in DNA/RNA synthesis and regulation; protein synthesis and degradation and 
ubiquitination (table 5.9). 
Table – 5.9 Summary of the MF ontology terms and respective p-value associated with the 
set of differentially expressed genes from CXCL12-over-control analysis. 
GOMFID Odds Ratio Term -log10(p-value) 
GO:0034593 10.951 
phosphatidylinositol bisphosphate 
phosphatase activity 
3 
GO:0070064 10.373 proline-rich region binding 2.69897 
GO:0008175 9.796 tRNA methyltransferase activity 2.522879 
GO:0017025 9.796 TBP-class protein binding 2.522879 
GO:0019787 8.769 ubiquitin-like protein transferase activity 2.154902 
GO:0008353 8.642 
RNA polymerase II carboxy-terminal 
domain kinase activity 
2.154902 
GO:0010485 8.642 H4 histone acetyltransferase activity 2.154902 
GO:0004709 7.207 MAP kinase kinase kinase activity 3 
GO:0004298 5.474 threonine-type endopeptidase activity 2.221849 
GO:0004708 5.474 MAP kinase kinase activity 2.221849 
GO:0019200 5.186 carbohydrate kinase activity 2.09691 
GO:0016538 4.804 
cyclin-dependent protein serine/threonine 
kinase regulator activity 
2.69897 
GO:0051721 4.804 protein phosphatase 2A binding 2.69897 
GO:0004712 4.618 
protein serine/threonine/tyrosine kinase 
activity 
2.522879 
GO:0008200 4.614 ion channel inhibitor activity 3 
GO:0031369 4.419 translation initiation factor binding 2.30103 
GO:0051539 4.038 4 iron, 4 sulfur cluster binding 3 
GO:0017048 3.93 Rho GTPase binding 3 
GO:0043022 3.806 ribosome binding 3 
GO:0016896 3.747 
exoribonuclease activity, producing 5'-
phosphomonoesters 
2.30103 
GO:0031492 3.747 nucleosomal DNA binding 2.30103 
GO:0019213 3.691 deacetylase activity 2.69897 
GO:0008536 3.458 Ran GTPase binding 2.045757 
GO:0061631 3.458 ubiquitin conjugating enzyme activity 2.045757 
GO:0003755 3.364 
peptidyl-prolyl cis-trans isomerase 
activity 
2.69897 
GO:0016627 3.234 
oxidoreductase activity, acting on the 
CH-CH group of donors 
2.221849 
GO:0050681 3.172 androgen receptor binding 2.522879 
GO:0019003 3.101 GDP binding 3 
GO:0030374 3.029 
ligand-dependent nuclear receptor 
transcription coactivator activity 
3 
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GO:0019900 2.785 kinase binding 3 
GO:0008094 2.748 DNA-dependent ATPase activity 2.39794 
GO:0048365 2.718 Rac GTPase binding 2.154902 
GO:0005080 2.628 protein kinase C binding 2.39794 
GO:0003727 2.623 single-stranded RNA binding 3 
GO:0004860 2.623 protein kinase inhibitor activity 3 
GO:0004722 2.356 
protein serine/threonine phosphatase 
activity 
2.522879 
GO:0019903 2.349 protein phosphatase binding 3 
GO:0001104 2.278 
RNA polymerase II transcription cofactor 
activity 
3 
GO:0061733 2.211 
peptide-lysine-N-acetyltransferase 
activity 
2.154902 
GO:0043566 2.2 structure-specific DNA binding 3 
GO:0017137 2.181 Rab GTPase binding 3 
GO:0003729 2.068 mRNA binding 3 
GO:0002020 2.009 protease binding 3 
5.9. Pathway enrichment analysis 
In modern molecular biology, identification of associations between an input set of gene and 
annotated gene sets (e.g., pathways) is an important problem. Tailor pipeline identified 39 
differentially expressed pathways and Ubiquitin-mediated proteolysis is the most 
significantly differentially expressed pathway (Fig. 5.9). ECM deposition is the common 
feature of fibrotic disease which interrupts the normal structure of the affected organs and 
leading to their dysfunction and failure. Degradation of protein via the ubiquitin-proteasome 
system is the significantly differentially expressed pathway that controls many critical 
cellular functions including cell-cycle progression, cell growth, and differentiation (Chen and 
Dou 2010). Anomalous alterations of expression of genes associated with proteasome 
pathway dysregulated cellular homeostasis and development of cancers, fibrosis, and 
neurodegenerative disorders, etc. Although the ubiquitin-mediated proteolysis mainly 
investigated in the field of cancers, recent transcriptomics of stromal fibroblast cell line data 
analysis revealed ubiquitin-mediated proteolysis may provide a rational basis for the 
discovery of novel therapy for fibrotic diseases and the consisted genes of this pathway are 
the part of multi-subunit RING-finger type 3 Cullin-RBX E3. Cullin proteins are molecular 
66 
 
scaffolds and essentially responsible for the assembly of Cullin-RING ubiquitin ligases 
(CRLs) that leads to ubiquitin-mediated proteolysis by facilitating the covalent attachment of 
ubiquitin group to target proteins. SEC31 is the target substrate of the Cullin-RING ubiquitin 
ligase complex. 
SEC31 monoubiquitination by CUL3-KLHL12 is necessary for the oversize COPII vesicle 
formation (Patalano 2018) and genes encoding the CUL3, KLHL12, and SEC23 proteins 
were differentially expressed by CXCL12- compared to TGFβ- treated cells. Other genes 
such as SCAP that preferentially up-regulated by the CXCL12/CXCR4 axis and associated 
with COPII vesicle-mediated ER-to-Golgi protein secretion (Patalano 2018); finally, it may 
be concluded these group of genes have a prospective role of CXCL12/CXCR4-mediated 
initiation of COPII vesicle formation and fibroblast to myofibroblast phenoconversion. 
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CHAPTER 6 
DISCUSSION 
There were many contributors that are involved in the metabolic disease and NAFLD disease 
progression. These factors may need to understand that can aid to diagnosis of these diseases. 
Previous studies suggested SAMP6 mice are associated with type 2 diabetes mellitus 
(Gharaee-Kermani 2013). In our current work, we have mainly elucidated the transcriptional 
regulation of genes that are associated in NAFLD. Now to initiate the NAFLD and the other 
associated diseases, inflammation play a pivotal role. In HFD-fed mice compared to LFD-fed 
mice analysis, several genes were overexpressed, and it’s expected to find some significantly 
differentially expressed genes that were associated with metabolic syndrome-induced 
inflammation of liver. In addition to this, we have also observed several downregulated genes 
that might expect to play liver organ dysfunction. On the other hand, cell signaling pathway 
identification is also a main target in our analysis to know how HFD fed mice associated with 
liver disease. In our analysis, HFD-fed mice, the significant “PPAR-Gamma signaling 
pathway” was the top up-regulated pathway. Accumulation of excess white adipose tissue 
(WAT) can lead to develop inflammation, metabolic syndrome, type 2 diabetes, and NAFLD 
(Jung and Choi 2014). In SAMP6 mice accumulation of excess WAT or fat has been 
observed compare to the low-fat diet mice. This can be an explained due to the direct effect 
of excess WAT that may contribute the inflammation aspect. Previously it has been reported 
that under the same dietary conditions SAMP6 strain mice are able to progress several 
disease concerns (Brenner 2000). As previously reported result from our research group, 
these SAMP6 mice espoused type II diabetes which is a risk factor to emerge NAFLD. Taken 
together these data it may be concluded that SAMP6 mice model which has been used in this 
study, is able to instigate the metabolic syndrome disease which may develop to NAFLD. 
Therefore, we have showed, for the first-time alteration of immune-response, downregulation 
of metabolic processes that allowed us to study the unique transcriptional response to 
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NAFLD, which can aid to understand further knowledge in liver disease and cancer. In this 
analysis, we have failed to observe alteration of growth factors, heat shock proteins whereas 
elevation of collagen has been observed. This insinuates to the development of early stages of 
tumorigenesis and hepatocellular carcinoma which is a unique signature of NAFLD. 
Hepatocellular carcinoma and cirrhosis are strongly associated with NAFLD if it’s not treated 
(Cholankeril 2017). Though current studies revealed several biomarkers have been identified 
that were associated with Hepatocellular Carcinoma, we intended to observe any significantly 
differentially expressed genes that may act as a significant biomarker in HFD-fed mice to 
LFD-fed mice.  
Recent studies showed that deposition of collagen, extracellular matrix (ECM) are 
associated with fibrosis that can contribute to the etiology of LUTS. It is reported 
microenvironment of aging prostate tissue contained ample amount of inflammatory proteins 
particularly CXC-type chemokines (Rodriguez-Nieves 2013) whether these proteins can 
mediate fibroblast to myofibroblast phenoconversion is still under suspicion. It is well known 
that CXCL12 and TGFβ are inflammatory cytokines and achieved diverse cellular functions 
such cellular proliferation and differentiation (Huang 2009). TGFβ is well known pathogenic 
effector of fibrosis and it acts as a driving factor to promote fibroblast to myofibroblast 
phenoconversion, and ECM deposition (Rodriguez-Nieves 2013). However, in prostate 
stroma several C-X-C type chemokines such as CXCL1, CXCL2, CXCL3, CXCL8, and 
CXCL12 are altered and secreted and associated with benign hyperplasia (Gharaee-Kermani 
2012). Previously, it was reported that, MAP Kinase signaling pathway activated by both 
CXCl12 and TGFβ. Previous report suggested TGFβ promoted fibroblast to myofibroblast 
phenoconversion in a Smad-dependent manner whereas CXCL12/CXCR4 achieved this 
phenoconversion by transactivating EGFR and promoting downstream MAPK signaling 
(Rodríguez-Nieves 2016). As a result, activation of these signaling cascades promoted the 
activation of the COL1A1 and COL1A2 genes and finally involved in the production of 
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procollagen protein. Accumulation of the extra cellular matrix deposition is a characteristic 
feature of fibroblast to myofibroblast phenoconversion and hallmark of tissue fibrosis 
(Gharaee-Kermani 2012). It is important to understand the underlying mechanism how 
CXCL12 and TGFβ concurrently promote fibrosis through transactivating of collagen. 
Treated the stromal fibroblasts cells with both CXCL12 and the TGFβ, followed by perform 
the transcriptomics analysis reveal interesting result which may be a remarkable feature for 
the myofibroblast phenoconversion. The remarkable distinguishing feature is an increased 
expression of ubiquitination/polyubiquitination with activation of the CXCL12, compared to 
TGFβ. Previously report suggested CXCL12 specifically activates the transcriptional 
response in the human prostate and epithelial cells. This activated transcriptional signal 
promotes cellular proliferation of stromal prostate epithelial cells which concurrently 
activates genes encoding proteins that promotes cellular proliferation (Begley 2008). In this 
analysis we have observed several CUL proteins that were over-expressed and in human 
these proteins may play an important role to promote CXCL12/CXCR4-mediated cellular 
proliferation and myofibroblast phenoconversion. In ubiquitin mediate proteolysis we found 
Cul4A is upregulated upon the treatment with CXCL12. In addition to Cul4A, CUL1 is 
upregulated in this analysis. So, it is still an unexplored area of research whether these CUL 
proteins may initiate to promote CXCL12/ CXCR4-mediated cellular proliferation and 
myofibroblast phenoconversion. Another molecular mechanism found in this analysis is 
several miRNAs are regulated by both CXCL12 and TGFβ which, in turn, inhibit the 
translation of mRNAs. Consistent with our analysis, we are trying to find out whether both 
similar and dissimilar subsets of miRNAs are activated by TGFβ/TGFβR axis compared to 
the CXCL12/CXCR4 axis because microRNA plays a crucial role in controlling cell 
migration and invasion (Baranwal and Alahari 2010). Alteration of miRNAs expression is 
widely altered in cancer, suggesting that deregulations of miRNAs are deeply associated in 
the development of tumor and cancer progression (Liu 2011). We found miR100HG, 
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miR22HG; miR210HG, miR663A, and miR663AHG are upregulated in CXCL12/CXCR4 
axis compared to the TGFβ/TGFβR axis. Previous report suggested deregulation of miRNAs 
including miR-15, miR-16 have been associated with cancer progression (Liu 2011). So, 
further studies are required to decipher whether they promote fibroblast to myofibroblast 
phenoconversion. Recent studies from this analysis demonstrated significant amount of long 
non-coding RNAs (lncRNAs) which are upregulated in CXCL12/CXCR4 axis compared to 
TGFβ/TGFβR axis. LncRNAs are more than 200 nucleotides in length that have deficiency 
of protein-coding capacity (Spurlock 2016). LncRNAs regulated fibrosis by deposition of 
ECM that concomitantly stimulates the accumulation of collagen and glycosaminoglycans 
(Zhang 2018). LncRNAs are a functional and stable part of a genome and plays important 
biological roles such as cellular-, structural- processes that direct towards the complexity of 
an organism. Based on the stromal fibroblast cell line analysis, we are trying to find out 
whether any lncRNAs that may regulate fibroblast to myofibroblast phenoconversion. Our 
analysis demonstrated several lncRNAs including MALAT1, NEAT1, TUG1, PTENP1, 
Kcnq1ot1, DNM3OS and Scarb2 are upregulated in both TGFβ/TGFβR axis and 
CXCL12/CXCR4 axis. So, it’s still an unexplored area of research whether lncRNAs play a 
pivotal role in fibroblast to myofibroblast phenoconversion.  
Recently, research on miRNAs have been increasingly rapidly. Several studies have 
demonstrated that certain miRNAs are specifically correlated with certain cancer and the 
different expression level of miRNAs presumably function as an indicator for cancer 
metastasis and prognosis. The function of the lncRNA hostgenes MIR22HG and MIR100HG 
within this ncRNA ensemble remained elusive. Given the large-scale regulation of miRNAs 
in stromal fibroblast, it may possible these miRNAs are directly linked to myofibroblast 
phenoconversion. Notably, upregulation of miR100HG and miR22HG, may involve cell 
proliferation, migration, and invasion which holds true for the assumption, these miRNAs 
play an important role in fibroblast to myofibroblast phenoconversion. Thus, expression 
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patterns of miR22HG and miR100HG transcripts implicate an independent, yet unknown 
function in the context of myofibroblast phenoconversion. Therefore, loss-and gain function 
need to be performed to elucidate the role of these miRNAs in myofibroblast 
phenoconversion. 
Over the past decade, role of AARS/AARS2 have been overlooked due to their prime 
function as a protein translation. However, recent high throughput sequencing provided a 
platform to revisit their role. Due to their pleiotropic role in protein translational regulation, 
cell signaling and amino acid metabolism, dysregulation of ARS genes has been associated 
with tumorigenesis. In this report, we investigated ARS gene expression in human stromal 
fibroblast to decipher their role in myofibroblast phenoconversion. RNA-Seq analyses of 9 
datasets from stromal fibroblast cell line indicates anomalous expression of ARS in human 
fibroblast cell line. Aberrant expression of AARS genes shows upregulation of several AARS 
genes such as IARS, IARS2, EPRS, LARS, NARS, TARS, WARS2. The ARS/ARS2 genes 
arose early in evolution, and perchance, because of their presence from the beginning, these 
genes have been available for adaptation and recruitment to emerging cell signaling 
pathways, even those related to cancer. This functional flexibility allows ARS/ARS2 genes to 
play role in pathways other than protein synthesis. Clearly, the increase of ARS/ARS2 gene 
expression support increased protein synthesis in cancer cells and drives cell transformation. 
NARS is also involved in differentiation, presumably contributing to carcinogenesis. NARS, 
a class II ARS, identified as an up-regulated protein in this study. Our findings demonstrate 
that NARS is involved in cell proliferation, differentiation. Moreover, the current study 
demonstrated a novel role of NARS in promoting the migration ability of stromal fibroblast. 
On the other hand, WARS2 which is a mitochondrial aminoacyl tRNA synthetase gene 
involved in angiogenesis. Angiogenesis is an important factor playing a pivotal role in cancer 
cell metastasis and proliferation. Though these ARS/ARS2 genes are often considered as 
housekeeping genes recent evidence and our study clearly shows that their basal level of 
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expression to carry out normal physiological processes are often perturbed in disease 
condition. Our findings indicate that increase of the ARS/ARS2 genes must benefit fibroblast 
cells in some way favoring their survival and proliferation. How these genes promote 
myofibroblast phenoconversion are working in concert, if any, opens up a new arena of 
investigation. 
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CHAPTER 7 
CONCLUSION 
Emerging technological advances in genomics augmented an enormous amount of data at 
unprecedented high resolution (Khatri 2012). High-throughput sequencing of RNA allowed 
us to provide simultaneous measurement of RNAs sequence and expression at whole cellular 
level (Wang 2009). With the introduction of these new technologies, new bioinformatic 
approaches are required to analyze gigantic amount of data. In this thesis we have developed 
a pipeline for the analysis of RNA-Seq data and made contributions to the understanding of 
diet induced mouse model that are associated with the non-alcoholic fatty liver disease and 
the fibroblast to myofibroblast phenoconversion by using the human stromal fibroblast cell 
line.  
Widespread genome-wide transcriptome study reconciled by high throughput sequencing 
technique has revolutionized the study of genetics at unprecedented resolution. Recent 
research divulged that an enigmatic amount of regulatory coding and non-coding RNAs 
encoded in human transcriptome (Tripathi 2017). Previous report suggested many 
unmentionables technology has been developed and categorized these non-coding RNAs as 
dark matter” and “junks”. To debunk that idea, RNA-seq is an experimental technique that 
has been revolutionized and widely being used for studying non-coding RNAs recently due to 
its physiological and pathological significance.  
First, we have implemented a complete pipeline to analyze RNA-Seq data. This pipeline 
begins by performing a data quality assessment, next it aligns the cleaned reads to a reference 
genome, measures the data gene expression level, tests for differential expression and, finally, 
concatenates this data into GO terms to find out significant ontology terms that has been 
associated with the biological problems. The outcome of this pipeline is a table that contains 
the differentially active cellular process between the RNA-Seq samples being processed. This 
enables the user to draw patterns for cataloguing gene function from high-volume data. 
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Subsequently, we have included a step that can able to investigate if a certain biological 
pathway that is significantly differentially expressed on a given RNA-Seq dataset. In RNA-
Seq, the major problem in determining the conclusions is due to the low number of replicate 
samples. Lower number of biological replicates in RNA-Seq dataset provides a poor 
statistical significance. To overcome this problem, tailor pipeline incorporated cuffdiff step 
that perform a differential gene expression analysis. Gene ontology analysis is important to 
find the certain biological processes and molecular functions of the differentially expressed 
genes and it’s a common approach for the gene set enrichment analysis. The motivation 
behind the introduction of Gene Ontology (GO) has grown to be the largest resource of its 
type which infers functional relationship of the differential gene. In tailor pipeline we have 
added this gene ontology step that will provide the functionality of known and newly 
discovered genes. To detect an association between set of input gene and sets of an annotated 
gene is a prime interest in molecular biology. To overcome this problem, we have included a 
pathview step in the pipeline to identify the differentially regulated pathways. It maps and 
delivers user data on relevant pathway graphs based on the array of gene interest. Pathway 
analysis is useful for the validation of the conclusions extracted from user biological 
problems. It’s hopeful this complete package of pipeline can be useful not only for 
bioinformaticians but also for biologists in the future detect novel gene and their target 
pathway associated with any biological phenotype. 
To evaluate the developed tools, we have studied two biological problems such as a diet 
induced SAMP6 mouse RNA-Seq dataset and the stromal fibroblast cell line dataset to study 
the myofibroblast phenoconversion. In the diet induced SAMP6 mice system transcriptome 
was collected from population of cells infected with high fat diet and low-fat diet. On the 
other hand, transcriptomics analysis performed on stromal fibroblast cell line data set which 
is characterized by the induction of CXCL12 and TGFβ.  
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Regarding the analysis of these datasets with the developed pipeline, it was possible to 
extract biological meaningful conclusions. To initiate metabolic syndrome, fat, high blood 
pressure, and elevated glucose levels are the key factors to promote metabolic syndrome in 
diet induced SAMP6 mice model system which concurrently initiate to develop diabetes, 
heart disease and finally cancer. Understand the transcriptional landscape is an important 
factor that can able to diagnose of these diseases. Until date, several studies reported that 
development of metabolic syndrome has been shown to be very closely associated with lack 
of physical activity and consequently it provides a tendency to rise of obesity rates among 
adults. Often NAFLD highly associated with the development of metabolic syndrome that 
can lead to liver dysfunction, cirrhosis of liver, and hepatocellular carcinoma. Previous 
studies showed SAMP6 mice can develop type-2 diabetes, a key factor to reduce the quality 
of life and health of the mice. We are trying to investigate how NAFLD affect the 
transcriptional landscape in liver pathophysiology. Transcriptomics analysis of HFD-fed mice 
showed many genes were up-regulated when compared to LFD-fed mice and associated with 
inflammations. It insinuates us to find any immune-related genes in our dataset that might be 
correlated between metabolic syndrome and inflammation which is not previously been 
stated. Additionally, this analysis showed some down-regulated genes associated with 
metabolic processes, which was able to point towards the fatty liver organ dysfunction. On 
the other hand, in HFD-fed mice, the significant up-regulated “PPAR-gamma signaling” 
pathway was the top up-regulated pathway in our study. Emergence of next generation 
sequencing technology showed HFD induced SAMP6 mice showed liver enlargement with 
accumulation of fat which conclude our mice might suffer from NAFLD. Several biological 
processes involved in including inflammation, metabolism, cellular stress responses, and 
ECM deposition have allowed us to scrutinize this exceptional transcriptional rejoinder to 
NAFLD, which can support in further understanding this disease. In our study, we have failed 
to find any cancerous or fibrotic phenotype of SAMP6 mice upon treatment with high fat 
76 
 
diet. However, growth factors such as EGF1, EGF2, and heat shock proteins, and collagen 
such as COL1, COL3 so on which have been overexpressed in this study and suspecting they 
are associated early stages of tumorigenesis and hepatocellular carcinoma. Finally, we were 
able to find the transcriptional association and the hallmark that are associated with NAFLD 
and early stages of tumorigenesis. Finally, molecular fibrosis signature associated with 
NAFLD disease increases our understanding towards the cellular response in mice model 
which is a novel approach towards the better understanding of translational application of the 
human fibrosis processes. 
To strengthen the reliability of the tailor pipeline, a new dataset, with more robust 
information, has been processed by using the developed pipeline described above. In the new 
dataset we have aimed tissue fibrosis which is reconciled by the associations of several pro-
fibrotic proteins that induce fibroblast to myofibroblast phenoconversion. Previous report 
suggested fibroblast to myofibroblast phenoconversion occurs through Smads and MEK/Erk 
proteins independently. In this study, we have treated the stromal fibroblast cell line with 
TGFβ/TGFβR and CXCL12/CXCR4. Previously, several reports suggested TGF-β1 
promoted the transcription of both αSMA and COL1, which is coupled to myofibroblast 
phenoconversion. We therefore aimed whether CXC-type chemokines upregulated the level 
of αSMA and COL1 expression. Transcriptomics analysis reveals several upregulated 
transcripts COL1A1 and COL1A2 genes and resulted in increased levels of procollagen 
production, characteristic of myofibroblast phenoconversion. This analysis divulged 
unreported pathway name as ubiquitin mediated proteolysis, activates COPII-mediated 
vesicle formation responsible for transportation of large cargo complex, from the 
endoplasmic reticulum (ER) to the Golgi apparatus. Therefore, induction of 
CXCL12/CXCR4 facilitates the procollagen secretion and initiates ECM deposition which is 
a characteristic of tissue fibrosis. Several upregulated transcripts reported in this analysis 
such as CUL3 and KLHL12 are promoted in increased level of procollagen secretion, 
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transported from the ER to the Golgi in prostatic fibroblast. Increased level of procollagen 
promotes ECM deposition, hallmark of tissue fibrosis.  Earlier transcriptomics analysis 
identified protein-coding genes only. Recently emerging technological innovation upfront 
multifarious capability identified uncharacterized ncRNAs, figuring out its biological 
significance. Tailor pipeline enables us to identify 15 differentially expressed ncRNAs in the 
stromal fibroblast analysis. It is noteworthy MALAT1, NEAT1, TUG1, PTENP1, Kcnq1ot1, 
DNM3OS and Scarb2 that were significantly differentially expressed in CXCL12/CXCR4 
axis and the TGFβ/TGFβR axis, insinuating us to perform further research to decode their 
role in fibroblast to myofibroblast phenoconversion. In conclusion, the results of this study 
further highlight the pivotal roles played by ncRNAs in mediating changes in gene expression 
and cell functions occurring during pulmonary fibrosis. In particular, our results identified 
these lncRNAs as a new determinant of prostatic fibrosis and mechanistically ascribed its 
profibrotic effect to the regulation of myofibroblast phenoconversion leading to CXCL12 and 
TGF-β-dependent activation of stromal fibroblasts. We thus anticipate this analysis may 
represent a new effective therapeutic option to treat fibrosis in the future. Recent report 
suggested that over expression of MALAT1 may contribute to the development of fibrosis in 
non-alcoholic steatohepatitis (NASH) in liver through mechanisms involving inflammatory 
C-X-C motif chemokine ligand 5 (CXCL5) (Leti 2017).  It may be concluded that potential 
consequence of myofibroblast phenoconversion may be associated with impaired smooth 
muscle activity, disrupted smooth muscle function and consequently deposition of ECM.  
To regulate gene expression at the post-transcriptional and translational level, miRNAs 
play an important role (Morris et al. 2004). Based on gene ontology and literature mining, 
revealed their involvement to regulate cellular proliferation and cellular growth. In this study, 
miR22HG and miR100HG are presented strong evidence these miRNAs expressed 
significantly. However, their role in the context of myofibroblast phenoconversion and 
accumulation of ECM is still an open area of research and whether under-expression of 
78 
 
MIR22HG and MIR100HG have the optimal specificity and sensitivity for liver cancer 
diagnosis also needs future confirmation. 
From this analysis it is clear that not all ARS/ARS2 genes are altered in cancer rather 
that they are cancer specific. This is presumably due to the codon bias for the oncogenes 
specific for a cancer. WARS2, though suspected, has never been implicated in fibrosis 
earlier. We provide here direct evidence of anomalous WARS2 and NARS expression in 
myofibroblast phenoconversion.  In general, our study collectively implies that genes like 
AARS/AARS2 which are often designated as housekeeping are dysregulated in disease 
condition and plays an important role in cancer cell survival/proliferation.  
The pipeline described in this thesis will provide a new arena in the field of genomics 
research. With the rapid advancement of sequencing technology coupled with augmented 
knowledge of the role of genomics in human disease, speeded up for the diagnosis for 
patients. We believe, the increasing 'mainstreaming' of whole genome sequencing is 
important of genomics research for many clinicians. Hope tailor pipeline will endow with a 
genomics research and its clinical applications, including its contribution to personalized 
medicine.  
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